Transformed plant with Bacillus thuringiensis toxin gene

FIELD OF THE INVENTION
The present invention relates to lepidopteran-toxic proteins and the genes coding therefor. In particular, the present invention is directed to genes designated as cryET4 (SEQ ID NO:1) and cryET5 (SEQ ID NO:3) and their proteins designated respectively as CryET4 (SEQ ID NO:2) and CryET5 (SEQ ID NO:4).
BACKGROUND OF THE INVENTION
Bacillus thuringiensis (commonly known as B.t.) is a gram-positive soil bacterium that often produces cellular inclusions during sporulation which are specifically toxic to certain orders and species of insects. Many different strains of B.t. have been shown to produce these inclusions of insecticidal crystal protein (ICP). Compositions including B.t. strains which produce insecticidal proteins have been commercially available and used as environmentally acceptable insecticides because they are quite toxic to the specific target insect, but are harmless to plants and other non-targeted organisms.
B.t. ICP toxins are active in the insect only after ingestion. After ingestion by an insect, the alkaline pH and proteolytic enzymes in the mid-gut solubilize the crystal allowing the release of the toxic components. These toxic components disrupt the mid-gut cells resulting in cessation of feeding and, eventually, death of the insect. B.t. has proven to be an effective and environmentally safe insecticide in dealing with various insect pests.
A number of genes encoding crystal proteins have been cloned from many strains of B.t. A good overview is set forth in H. Hofte and H. R. Whiteley, Microbiol. Rev., 53, pp. 242-255 (1989), hereinafter "Hofte and Whiteley (1989)." This reference provides a good overview of the genes and proteins obtained from B.t. and their uses, adopts a nomenclature and classification scheme for B.t. genes and proteins, and has an extensive bibliography.
The nucleotide sequences of ICP genes responsible for a given crystal phenotype and active against the same insect order are generally more related, i.e., more homologous, than are the nucleotide sequences of B.t. genes encoding delta-endotoxin proteins active against different orders of insects. Hofte and Whiteley (1989) defines an ordered classification of genes encoding B.t. delta-endotoxin proteins based on homology of delta-endotoxin amino acid sequences, as well as similarities in insecticidal activity; a subranking has also been established based upon further refinement of sequence relationship. As noted by Hofte and Whiteley (1989), the majority of insecticidal B.t. strains are active against insects of the order Lepidoptera, i.e., caterpillar insects. Insecticidal crystal proteins specifically active against Lepidoptera have been designated CryI proteins. These ICPs are encoded by cryI genes. Other B.t. strains produce different classes of crystal proteins, e.g., CryII proteins are active against lepidopteran and (for CryIIA) dipteran insects; CryIII proteins are insecticidal to insects of the order Coleoptera, i.e., beetles; and CryIV proteins are active against insects of the order Diptera, i.e., flies and mosquitoes. A compilation of the amino acid identities for several CryI proteins as well as CryII, CryIII and CryIV proteins has been determined in Hodgman and Ellar, J. DNA Sequencing and Mapping, 1, pp. 97-106 (1990).
The CryI family of ICPs contains the largest number of known toxin genes derived from B.t., as evidenced by the survey in Hofte and Whiteley (1989) and by subsequent reports of CryI-type ICPs.
Schnepf et al., J. Biol. Chem., 260, pp. 6264-6272 (1985), reported the complete nucleotide sequence for a toxin gene from B.t. kurstaki HD-1. This gene was subsequently classified as cryIA(a) by Hofte and Whiteley (1989). The published open reading frame extends 1176 amino acids and encodes a protein with a calculated molecular mass of 133,500 Daltons (Da). Another gene, also classified as cryIA(a), was isolated from B.t. subsp. kurstaki HD-1 Dipel.RTM. by Shibano et al., Gene 34, pp. 243-251 (1985). As detailed in Table 2 of Hofte and Whiteley (1989), this gene is highly related, especially in the N terminal moiety, to cryIA(a) reported by Schnepf et al. (1985). CryIA(a) protein is broadly active against Lepidoptera; Hofte and Whiteley (1989) reports that four of five tested lepidopteran insects were sensitive to this toxin.
Other ICP genes subsequently identified as cryIA(a) that are greater than 99% identical to the holotype cryIA(a) gene have been identified in B. thuringiensis subspecies aizawai, (Shimizu et al., Agric. Biol. Chem., 52, pp. 1565-1573 (1988)), subspecies kurstaki, (Kondo et al., Agric. Biol. Chem., 51, pp. 455-463 (1987)), and subspecies entomocidus (Masson et al., Nucleic Acids Res. 17, p. 446 (1989)). The cryI-type nucleotide sequence disclosed in European Patent Application Publication No. 0 367 474, published May 9, 1990, of Mycogen Corporation, reveals a DNA sequence related to the cryIA(a) gene and its encoded protein that is 92% positionally identical to the holotype CryIA(a) ICP.
Wabiko et al., DNA, 5, pp. 305-314 (1986), describe the DNA sequence of an insecticidal toxin gene from B.t. subsp. berliner 1715, subsequently classified as cryIA(b) by Hofte and Whiteley (1989). The molecular mass of the protein encoded is 130,615 Da and sequential deletions indicate that the NH.sub.2 -terminal 612 amino acid polypeptide is toxic to lepidopteran insects. Hofte et al., Eur. J. Biochem., 161, pp. 273-280 (1986), describe the cloning and nucleotide sequencing of a variant crystal protein gene from B.t. subsp. berliner 1715, subsequently also classified as cryIA(b). The cloned gene produces an approximately 130,000 Da protein which coincides with the mass of the major protein observed in the strain. The gene has an open reading frame of 3465 bases which would encode a protein 1155 amino acids in length having a mass of 130,533 Da. Similarities of this sequence to the previously reported sequences for the cloned crystal genes from B.t. kurstaki HD-1, B. t. kurstaki HD-73 and B.t. sotto are discussed in the Hofte et al. (1986) paper. Data identifying a minimal toxic fragment required for insecticidal activity are also presented. The cryIA(b) gene discussed in Hofte et al. (1986) differs in its deduced amino acid sequence by only two amino acids from the CryIA(b) protein reported by Wabiko et al.
Other cryIA(b) genes have been disclosed in Geiser et al., Gene, 48, pp. 109-118 (1986), Hefford et al., J. Biotechnol., 6, pp. 307-322 (1987), Oeda et al., Gene, 53, pp. 113-119 (1987), Kondo et al., supra, Fischhoff et al., Bio/Technology, 5, pp. 807-813 (1987) and Haider and Ellar, Nucl. Acids Res., 16, p. 10927 (1988). Each of these six CryIA(b) ICPs is greater than 99% positionally identical to the holotype CryIA(b) toxin.
Adang et al., Gene, 36, pp. 289-300 (1985), report the cloning and complete nucleotide sequence of a crystal protein gene harbored on the 75 kilobase (kb) plasmid of strain B.t. subsp. kurstaki HD-73. The restriction map in the article identified this gene as holotype cryIA(c) under the current classification system of Hofte and Whiteley (1989). The complete sequence of the gene, spanning 3537 nucleotide base pairs (bp), coding for 1178 amino acids and potentially encoding a protein of 133,330 Da, is shown in the article. Toxicity data against Manduca sexta for the protein made by the cryIA(c) gene are also presented. CryIA(c) toxins have been isolated from several strains of B.t. subsp. kenyae that are highly related to the above-noted CryIA(c) toxin from B.t. subsp. kurstaki (greater than 99% positionally identical in deduced amino acid sequence) but whose protein products, although broadly active against lepidopteran insects, nonetheless show quantitatively different toxicities for individual insect species (Von Tersch et al., Appl. Environ. Microbiol., 57, pp. 349-358 (1991)).
Brizzard et al., Nucleic Acids Res., 16, pp. 2723-2724 (1988), describe the nucleotide sequence of crystal protein gene cryA4 (subsequently classified as cryIB by Hofte and Whiteley (1989)) isolated from B.t. subsp. thuringiensis HD-2. Hofte and Whiteley (1989) report an insecticidal specificity of CryIB toxin for Pieris brassicae.
Honee et al., Nucleic Acids Res., 16, p. 6240 (1988), describe the complete DNA sequence for the BTVI crystal protein gene isolated from B.t. subsp. entomocidus 60.5 (holotype cryIC by Hofte and Whiteley (1989)). This protein is reported to exhibit enhanced insecticidal activities against Spodoptera species.
Sanchis et al., Mol. Microbiol., 3, pp. 229-238 (1989) report the nucleotide sequence for the N-terminal coding region (2470 nucleotides) and 5' flanking region of a gene from B.t. subsp. aizawai 7.29 now classified as the cryIC gene under the classification system of Hofte and Whiteley (1989). Sanchis et al. disclose similar information about the cryIC gene in European Patent Application Publication No. 0 295 156, published Dec. 14, 1988. The open reading frame encodes a truncated polypeptide 824 amino acids long with a calculated mass of 92,906 Da.
A gene isolated from B.t. subspecies aizawai and now classified as holotype cryID under the Hofte and Whiteley (1989) system is disclosed in European Patent Application Publication No. 0 358 557, published Mar. 14, 1990 of Plant Genetic Systems, N. V. Hofte and Whiteley (1989) report selective lepidopteran toxicity against Manduca sexta for the CryID protein, the CryID toxin being largely inactive against other lepidopteran insects tested.
The holotype cryIE gene, found in a B.t. subspecies darmstadiensis strain, is disclosed in European Patent Application Publication No. 0 358 557, supra. A highly related cryIE gene from B.t. subsp. kenyae is disclosed by Visser et al., J. Bacteriol., 172, pp. 6783-6788 (1990).
Visser, Mol. Gen. Genet., 212, pp. 219-224 (1988) report the isolation and analysis of five toxin genes belonging to four different gene families from B.t. entomocidus 60.5, one of which is reported by Honee et al. (1988), supra. Two of these genes, BTIV and BTVIII, are cryIA(a)-type genes according to the Hofte and Whiteley (1989) classification scheme. The BTVI gene, also reported by Honee et al. (1988) supra, is a cryIC gene according to the Hofte and Whiteley (1989) classification scheme. The authors state that the restriction map for another gene, designated BTV, closely resembles that identified for the cryID gene isolated from B.t. strain HD68 subsp. aizawai, and disclosed in European Patent Application Publication No. 0 358 557, supra. A fifth gene, designated BTVII, is also identified and its restriction map differs significantly from the other four genes described. Toxicity data against several lepidopteran insects, S. exigua, S. littoralis, H. virescens and P. brassicae, are presented for each of the isolates. The BTV gene product was inactive against all insects tested. The BTVI protein is highly active against Spodoptera larvae, and the BTVII protein is toxic to P. brassicae.
Additional genes within the cryI family have been reported in the literature. A gene found in B.t. subsp. aizawai and described as cryIF is disclosed by Chambers et al. in J. Bacteriol., 173, pp. 3966-3976 (1991) and in PCT International Publication No. WO91/16434, published Oct. 31, 1991. A gene described as cryIG from B.t. subsp. galleria is disclosed by Smulevitch et al., FEBS Lett., 293, pp. 25-28 (1991). A gene that is highly related to the cryIG gene has been isolated from B.t. DSIR 517 by Gleave et al., J. Gen. Microbiol., 138, pp. 55-62 (1992).
A novel gene related to cryI-type genes is disclosed in PCT International Publication No. WO 90/13651, published Nov. 15, 1990, of Imperial Chemical Industries PLC. This gene encodes an 81 kDa polypeptide (Cry pJH11) that is broadly insecticidal and more distantly related to the family of cryI sequences than are most other reported cryI-type sequences. Four cryI-type sequences are disclosed in European Patent Application Publication No. 0 405 810, published Jan. 2, 1991, of Mycogen Corporation. Inspection of the cryI-type sequences revealed that one of the disclosed genes (cry 81IB2) belongs to the cryIC class, one (cry 81IB) belongs to the cryID class, and one (cry 81IA) belongs to the cryIF class. The fourth disclosed cryI sequence (cry 81IA2) appears to belong to a new class. Two cryI sequences are disclosed in European Patent Application Publication No. 0 401 979, published Dec. 12, 1990, of Mycogen Corporation. One of the disclosed sequences (PS82A2) appears to encode a novel gene, the other sequence (PS82RR) is highly related to the novel sequence cry 81IA2 disclosed in European Patent Application Publication No. 0 405 810.
Five novel cry sequences are disclosed in European Patent Application Publication No. 0 462 721, published Dec. 27, 1991, of Mycogen Corporation. These Cry proteins are reported to be nematocidal.
SUMMARY OF THE INVENTION
Briefly stated, one aspect of the present invention relates to a purified, isolated cryET4 gene having a nucleotide base sequence coding for the amino acid sequence shown in FIG. 1 and listed in SEQ ID NO:2.
The isolated cryET4 gene has a coding region extending from nucleotide bases 99 to 3602 (including the stop codon) in the nucleotide base sequence shown in FIG. 1 and listed in SEQ ID NO:1.
The present invention also relates to the isolated CryET4 protein which is obtainable from the cryET4 gene, and which has the amino acid sequence shown in FIG. 1 (SEQ ID NO:2), and which is insecticidal to lepidopteran insects.
Another aspect of the present invention relates to a purified, isolated cryET5 gene having a nucleotide base sequence coding for the amino acid sequence shown in FIG. 2 and listed in SEQ ID NO:4.
The isolated cryET5 gene has a coding region extending from nucleotide bases 67 to 3756 (including the stop codon) in the nucleotide base sequence shown in FIG. 2 and listed in SEQ ID NO:3.
The present invention also relates to the isolated CryET5 protein which is obtainable from the cryET5 gene, and which has the amino acid sequence shown in FIG. 2 (SEQ ID NO:4), and which is insecticidal to lepidopteran insects.
Additionally, the present invention relates to biologically pure cultures of a Bacillus thuringiensis bacterium designated as strain EG7279 transformed with a cryET4 gene having a coding region listed in SEQ ID NO:1 and strain EG7283 transformed with a cryET5 gene having a coding region listed in SEQ ID NO:3 or mutants thereof having insecticidal activity against lepidopteran insects susceptible to the CryET4 and CryET5 proteins, respectively.
The invention also relates to a biologically pure culture of a Bacillus thuringiensis bacterium designated as strain EG5847 or mutants thereof having insecticidal activity against lepidopteran insects susceptible to B.t. strain EG5847. B.t. strain EG5847 is a wild type isolate and is the B.t. strain from which the cryET4 and cryET5 genes were isolated.
Additional aspects of the present invention relate to recombinant plasmids containing the cryET4 and cryET5 genes; bacteria transformed with the recombinant plasmids and capable of expressing the cryET4 and/or cryET5 genes; insecticide compositions comprising the proteins and/or one or both of the transformed bacteria and/or other bacteria containing the CryET4 or CryET5 protein, with an agriculturally acceptable carrier; a method of controlling lepidopteran insects using the insecticides; plants transformed with and capable of expressing the cryET4 and/or cryET5 genes; and hybridization probes containing the cryET4 or cryET5 gene wherein the gene or at least an oligonucleotide portion of it is labeled for such use.

BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 comprises FIGS. 1A through 1J and shows the nucleotide sequence of the cryET4 gene (SEQ ID NO:1) and the deduced amino acid sequence of the CryET4 protein (SEQ ID NO:2).
FIG. 2 comprises FIGS. 2A through 2J and shows the nucleotide sequence of the cryET5 gene (SEQ ID NO:3) and the deduced amino acid sequence of the CryET5 protein (SEQ ID NO:4).
FIG. 3 is a photograph of an ethidium bromide stained agarose gel containing size-fractionated plasmids of B.t. strains EG5847 and HD-1, with plasmid sizes in megadaltons (MDa) being shown. The abbreviations in FIG. 3 are as follows: "ori" indicates the loading site and "lin" means linear DNA.
FIG. 4 is a photograph of a Coomassie blue stained gel containing size-fractionated proteins from B.t. strains EG5847, EG7279 and EG7283, obtained by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
FIG. 5 comprises FIGS. 5A and 5B and is a restriction map of the recombinant plasmids pEG291 (5A) and pEG1108 (5B), both of which contain the cloned cryET4 gene. The location and orientation of the cryET4 gene are indicated by the arrow.
FIG. 6 comprises FIGS. 6A, 6B, 6C and 6D and is a restriction map of the recombinant plasmids pEG292 (6A), pEG300 (6B), pEG1110,(6C) and pEG1111 (6D). Plasmids pEG292 and pEG300 contain 5' and 3' portions of the cryET5 gene, respectively. Plasmids pEG1110 and pEG1111 contain the entire cloned cryET5 gene. The location and direction of transcription of the cryET5 gene are indicated by the arrows.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Two novel Bacillus thuringiensis (B.t.) toxin genes, designated cryET4 (SEQ ID NO:1) and cryET5 (SEQ ID NO:3), were obtained from a novel B.t. isolate designated EG5847. Isolation of B.t. strain EG5847, isolation of the novel toxin genes cryET4 and cryET5, construction of Bacillus/E. coli shuttle vectors containing cryET4 (pEG1108) and cryET5 (PEG1111), and transformation of pEG1108 and pEG1111 into a B.t. host (B.t. strain EG10368) to produce recombinant B.t. strains EG7279 and EG7283 expressing respectively the CryET4 (SEQ ID NO:2) and CryET5 (SEQ ID NO:4) toxin protein gene products, are described generally in the Examples.
Subcultures of B.t. strains EG5847, EG10368, EG7279 and EG7283 were deposited in the permanent collection of the Agricultural Research Service Culture Collection, Northern Regional Research Laboratory (NRRL), U.S. Department of Agriculture, 1815 North University Street, Peoria, Ill. 61604, U.S.A. The accession numbers and deposit dates are as follows:
______________________________________Subculture Accession No. Deposit Date______________________________________B.t. EG5847 NRRL B-21110 June 9, 1993B.t. EG10368 NRRL B-21125 July 20, 1993B.t. EG7279 NRRL B-21112 June 9, 1993B.t. EG7283 NRRL B-21111 June 9, 1993______________________________________
These microorganism deposits were made under the provisions of the "Budapest Treaty on the International Recognition of the Deposit of Microorganism for the Purposes of Patent Procedure." All restrictions on the availability to the public of these deposited microorganisms will be irrevocably removed upon issuance of a United States patent based on this application.
The present invention is intended to cover mutants and recombinant or genetically engineered derivatives, e.g., truncated versions, of the cryET4 gene listed in SEQ ID NO:1 and the cryET5 gene listed in SEQ ID NO:3 that yield a protein with insecticidal properties essentially the same as those of the CryET4 protein listed in SEQ ID NO:2 and the CryET5 protein listed in SEQ ID NO:4. Likewise, the present invention covers those gene nucleotide base sequences that encode the amino acid sequences of the CryET4 protein (SEQ ID NO:2) and the CryET5 protein (SEQ ID NO:4). Variations may be made in the cryET4 and cryET5 gene nucleotide base sequences shown in FIGS. 1 and 2, respectively, and listed in SEQ ID NO:1 and SEQ ID NO:3, respectively, which do not affect the amino acid sequence of the gene product, since the degeneracy of the genetic code is well known to those skilled in the art. Moreover, there may be some variations or truncations in the coding regions of the cryET4 and cryET5 nucleotide base sequences which allow expression of the gene and production of functionally equivalent forms of the CryET4 and CryET5 insecticidal proteins. These variations or truncations, which can be determined without undue experimentation by those of ordinary skill in the art with reference to the present specification, are to be considered within the scope of the appended claims, since they are fully equivalent to the specifically claimed subject matter.
It has been shown that proteins of identical structure and function may be constructed by changing the amino acid sequence, if such changes do not alter the protein secondary structure (Kaiser and Kezdy, Science, 223, pp. 249-255 (1984)). Single amino acid substitutions have been introduced by site-directed mutagenesis at various positions of CryIA(a) toxin protein without altering the insecticidal properties of the parent toxin (Ge et al., Proc. Natl. Acad. Sci. USA, 86, pp. 4037-4041 (1989)). The present invention includes mutants of the amino acid sequences disclosed herein which have an unaltered protein secondary structure or, if the structure is altered, where the mutant has retained substantially equivalent biological activity compared to the unaltered protein.
The cryET4 gene (SEQ ID NO:1) and cryET5 (SEQ ID NO:3) gene are also useful as DNA hybridization probes, for discovering similar or closely related cryET4-type and cryET5-type genes in other B.t. strains. The cryET4 gene (SEQ ID NO:1) and cryET5 gene (SEQ ID NO:3), or unique portions or derivatives thereof capable of hybridizing selectively to a target nucleic acid, e.g., homologous oligonucleotides of 12 or more nucleotides, or larger portions of the genes, that contain nucleotide sequences unique to the cryET4 gene or cryET5 gene and that are different from similar sized nucleotide segments in known, prior art B.t. toxin genes, can be labeled for use as hybridization probes using conventional procedures. An exemplary label is a radioactive label.
Both the cryET4 gene (SEQ ID NO:1), its corresponding insecticidal CryET4 protein (SEQ ID NO:2) and the cryET5 gene (SEQ ID NO:2) and its corresponding insecticidal CryET5 protein (SEQ ID NO:4) were first identified in B.t. strain EG5847, a novel B.t. isolate. The characteristics of B.t. strain EG5847 are more fully described in the Examples.
The Bacillus strains described herein may be cultured using conventional growth media and standard fermentation techniques. The B.t. strains harboring the cryET4 gene (SEQ ID NO:1) or the cryET5 gene (SEQ ID NO:3), or both genes, may be fermented, as described in Example 1, until the cultured B.t. cells reach the stage of their growth cycle when the CryET4 crystal protein (SEQ ID NO:2) or the CryET5 crystal protein (SEQ ID NO:4) is formed. For sporogenous B.t. strains, fermentation is typically continued through the sporulation stage when the crystal protein is formed along with spores. The B.t. fermentation culture is then typically harvested by centrifugation, filtration or the like to separate fermentation culture solids containing the crystal protein from the culture medium.
The separated fermentation solids are primarily CryET4 crystal protein (SEQ ID NO:2) or CryET5 crystal protein (SEQ ID NO:4) and B.t. spores (if a sporulating host is employed), along with some cell debris, some intact cells and residual fermentation medium solids. If desired, the crystal protein may be separated from the other recovered solids via conventional methods, e.g., density gradient fractionation.
The B.t. strains exemplified in this disclosure are sporulating varieties (spore forming or sporogenous strains) but the cryET4 gene (SEQ ID NO:1) and cryET5 gene (SEQ ID NO:3) also have utility in asporogenous Bacillus strains, i.e., strains that produce the crystal protein without production of spores. It should be understood that references to "fermentation cultures" of B.t. strains containing the cryET4 gene (SEQ ID NO:1) or the cryET5 gene (SEQ ID NO:3) in this disclosure are intended to cover sporulated B.t. cultures, i.e., B.t. cultures containing the CryET1 crystal protein and spores, and sporogenous Bacillus strains that have produced crystal proteins during the vegetative stage, as well as asporogenous Bacillus strains containing the cryET4 gene (SEQ ID NO:1) or cryET5 (SEQ ID NO:3) gene in which the culture has reached the growth stage where the crystal protein is actually produced.
Mutants of B.t. strains harboring the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) can be made by procedures well known in the art. For example, an asporogenous mutant can be obtained through ethylmethane sulfonate mutagenesis. Mutants can also be made using ultraviolet light and nitrosoguanidine by procedures that are well known to those skilled in the art. References in this specification to "mutants" of wild-type or recombinant B.t. strains harboring the cryET4 gene or cryET5 gene refer to those derivatives which are capable of producing toxin protein exhibiting insecticidal activity against lepidopteran insects, at least equivalent to the insecticidal activity of the parent strain.
The CryET4 protein (SEQ ID NO:2) is an insecticidal compound active against a large number of lepidopteran insects, particularly those described in Example 4. The CryET4 protein (SEQ ID NO:2) may be used as the active ingredient in insecticidal formulations useful for controlling lepidopteran insects.
The CryET5 protein (SEQ ID NO:4) is an insecticidal compound active against a large number of lepidopteran insects, particularly those described in Example 4. The CryET5 protein (SEQ ID NO:4) may be used as the active ingredient in insecticidal formulations useful for controlling lepidopteran insects.
Such insecticidal formulations or compositions typically contain agriculturally acceptable carriers or adjuvants in addition to the active ingredient and are prepared and used in a manner well known to those skilled in the art.
The CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4) may be employed in insecticidal formulations in isolated or purified form, e.g., as the crystal protein itself. Alternatively, the CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4) may be present in the recovered fermentation solids, obtained from culturing of a Bacillus strain, e.g., Bacillus thuringiensis or other microorganism host carrying the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) and capable of producing the CryET4 or CryET5 protein. The CryET4 protein or CryET5 protein is thus associated with the B.t. bacterium which produced the protein, as an intimate mixture of crystal protein, cell debris and spores, if any, in the recovered fermentation solids. The recovered fermentation solids containing the CryET4 or CryET5 protein may be dried, if desired, prior to incorporation in the insecticidal formulation. Genetically engineered or transformed B.t. strains or other host microorganisms containing a recombinant plasmid that expresses the cloned cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3), obtained by recombinant DNA procedures, may also be used. For construction of recombinant B.t. strains containing either the cryET4 gene or cryET5 gene, B.t. var. kurstaki strain EG10368 is a preferred host, and this B.t. strain is utilized in Example 2. B.t. strain EG10368 is a crystal-negative, toxin plasmid-free, naturally occurring mutant of B.t. strain HD73-26 (described in U.S. Pat. No. 5,080,897, issued to Gonzalez, Jr. et al. on Jan. 14, 1992) that is highly transformable with recombinant plasmids, particularly those isolated from E. coli strains, e.g., DH5.alpha..
The formulations or compositions of this invention containing the insecticidal CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4) as the active component are applied at an insecticidally effective amount which will vary depending on such factors as, for example, the specific lepidopteran insects to be controlled, the specific plant or crop to be treated and the method of applying the insecticidally active compositions.
The insecticide compositions are made by formulating the insecticidally active component with the desired agriculturally acceptable carrier. The formulated compositions may be in the form of a dust or granular material, or a suspension in oil (vegetable or mineral), or water or oil/water emulsions, or as a wettable powder, or in combination with any other carrier material suitable for agricultural application. Suitable agricultural carriers can be solid or liquid and are well known in the art. The term "agriculturally acceptable carrier" covers all adjuvants, e.g., inert components, dispersants, surfactants, tackifiers, binders, etc. that are ordinarily used in insecticide formulation technology; these are well known to those skilled in insecticide formulation.
The formulations containing the CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4) and one or more solid or liquid adjuvants are prepared in known manners, e.g., by homogeneously mixing, blending and/or grinding the insecticidally active CryET4 or CryET5 protein component with suitable adjuvants using conventional formulation techniques.
The insecticidal compositions of this invention are applied to the environment of the target lepidopteran insect, typically onto the foliage of the plant or crop to be protected, by conventional methods, preferably by spraying. Other application techniques, e.g., dusting, sprinkling, soaking, soil injection, seed coating, seedling coating or spraying, or the like, are also feasible and may be required for insects that cause root or stalk infestation. These application procedures are well known in the art.
The cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) may be introduced into a variety of microorganism hosts without undue experimentation, using procedures well known to those skilled in the art for transforming suitable hosts under conditions which allow for stable maintenance and expression of the cloned genes. Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1982). Suitable hosts that allow the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) gene to be expressed and the CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4) to be produced include B.t. and other Bacillus species such as B. subtilis or B. megaterium. A general method for the transformation of Bacillus strains is provided by Macaluso et al. in J. Bacteriol., 173, pp. 1353-1356 (1991) and Mettus et al. in Appl. Environ. Microbiol., 56, pp. 1128-1134 (1990). Genetically altered or engineered microorganisms containing the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) can also contain other toxin genes present in the same microorganism; these genes could concurrently produce ICPs different from the CryET4 protein or CryET5 protein.
Plant-colonizing or root-colonizing microorganisms may also be employed as the host for the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3). Exemplary microorganism hosts for B.t. toxin genes include the plant-colonizing microbe Clavibacter xyli subsp. cynodontis, as described by Turner et al. in Appl. Environ. Microbiol., 57, pp. 3522-3528, and root-colonizing pseudomonad strains, as described by Obukowicz et al. in Gene, 45, pp. 327-331 (1986). Procedures such as those described by Turner et al. (1991) supra, and Obukowicz et al. (1986), supra, are well known to those skilled in the art and available for introducing the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) into such microorganism hosts under conditions which allow for stable maintenance and expression of the gene in the resulting transformants.
The transformants, i.e., host microorganisms that harbor a cloned gene in a recombinant plasmid, can be isolated in accordance with conventional methods, usually employing a selection technique, which allows growth of only those host microorganisms that contain a recombinant plasmid. The transformants then can be tested for insecticidal activity. These techniques are standard procedures well known to those skilled in the art.
Characteristics of particular interest in selecting a host cell for purposes of production include ease of introducing the gene into the host, availability of expression systems, efficiency of expression, stability of the CryET4 or CryET5 insecticidal protein in the host, and the presence of auxiliary genetic capabilities. The cellular host containing the insecticidal cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) may be grown in any convenient nutrient medium, where expression of the cryET4 gene or cryET5 gene is obtained and CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4) produced, typically to sporulation. The sporulated cells containing the crystal protein may then be harvested in accordance with conventional methods, e.g., centrifugation or filtration.
The cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3), particularly the toxin portion (N-terminal moiety) thereof, may also be incorporated into a plant which is capable of expressing the gene and producing CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4), rendering the plant more resistant to insect attack. Genetic engineering of plants with the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) may be accomplished by introducing the desired DNA containing the gene into plant tissues or cells, using DNA molecules of a variety of forms and origins that are well known to those skilled in plant genetic engineering. Examples of techniques for introducing DNA into plant tissue are disclosed in European Patent Application Publication No. 0 289 479, published Nov. 1, 1988, of Monsanto Company and by Perlak et al. in "Modification of the Coding Sequence Enhances Plant Expression of Insect Control Protein Genes," Proc. Natl. Acad. Sci. USA, 88, pp. 3324-3328 (1991).
DNA containing the cryET4 gene (SEQ ID NO:1) or cryET5 gene (SEQ ID NO:3) or a modified gene, operatively associated with a suitable plant promoter, e.g., CaMV35S, capable of effecting production of the CryET4 protein (SEQ ID NO:2) or CryET5 protein (SEQ ID NO:4), may be delivered into the plant cells or tissues directly by infectious plasmids, such as Ti, the plasmid from Agrobacterium tumefaciens, viruses or microorganisms like A. tumefaciens. Additionally, the use of lysosomes or liposomes, microinjection by mechanical methods and by other techniques familiar to those skilled in plant genetic engineering may be used.
The basic methods employed in the construction and evaluation of the recombinant plasmids and recombinant microorganism hosts described in this specification are generally well know to those proficient in the art of molecular cloning. Descriptions of these general laboratory procedures and definitions of nomenclature may be found in Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1982) and in a subsequent edition by Sambrook et al. (1989).
The characteristics of the CryET4 protein (SEQ ID NO:2) and CryET5 protein (SEQ ID NO:4), sequencing of the cryET4 gene (SEQ ID NO:1) and cryET5 gene (SEQ ID NO:3), comparison of sequence data to known B.t. toxin genes and insecticidal activity of the CryET4 and CryET5 proteins are described in the following specific, non-limiting examples.
EXAMPLE 1
Characterization of B.t. EG5847
B.t. strain EG5847 is a wild-type isolate, identified by visual examination of the colony as exhibiting a unique crystal morphology, and was isolated as a colony from maize dust. The colony contained endospores and bipyramidal and flat, diamond-shaped crystalline inclusions. Subsequent insect bioassay of this wild-type B.t. strain confirmed its insecticidal activity towards lepidopteran insects.
The complement of native plasmids contained within isolated B.t. EG5847 was determined by modified Eckhardt agarose gel electrophoresis as described by Gonzalez, Jr. et al., in Proc. Natl. Acad. Sci. USA, 79, pp. 6951-6955 (1982). The results, as shown in FIG. 3, revealed the presence of 5, 8, 12, 18 and 110 MDa plasmids. This pattern of native plasmids did not correspond to patterns typical of known serovars (Carlton and Gonzalez, pp. 246-252, in Molecular Biology of Microbial Differentiation, J. A. Hoch and P. Setlow, ed., American Society for Microbiology, Washington, D.C. (1985)).
Wild-type B.t. strain EG5847 was grown for five days at 25.degree. C. in DSM medium (described by Donovan et al. in Appl. Environm. Microbiol., 58, pp. 3921-3927 (1992)) until sporulation and cell lysis had occurred. Recombinant B.t. strains EG7279 (Example 2), containing the cryET4 gene, and EG7283 (Example 2), containing the cryET5 gene, were grown in DSM medium containing 3 .mu.g of chloramphenicol per ml in a similar manner. Fermentation solids containing spores and crystal proteins were isolated by centrifugation. Crystal proteins were purified from the spores and cell debris by sucrose density gradient centrifugation (described by Koller et al. in Biochem. Biophys. Res. Communic., 184, pp. 692-699 (1992)). Aliquots of the washed crystals were solubilized by heating in Laemmli buffer (10% (w/w) glycerol, 5% (w/w) 2-mercaptoethanol, 1% (w/v) SDS, 0.188 M Tris HCl pH 6.8, 0.01% (v/v) bromphenol blue) at 100.degree. C. for 5 minutes. The solubilized crystal proteins were size fractionated by SDS-polyacrylamide gel electrophoresis. After size fractionation, the proteins were visualized by staining with Coomassie Blue R-250 dye.
FIG. 4 shows the results of these protein size fractionation analyses where lane 1 is a molecular mass size standard, lane 2 is B.t. strain EG5847, lane 3 is B.t. strain EG2729 and lane 4 is B.t. strain EG7283. The numbers on the left side indicate the apparent molecular masses, in kilodaltons (kDa), of the crystal proteins synthesized by the B.t. strains. As shown in lane 3, a crystal protein having a mass of approximately 130 kDa was observed from EG7279. As shown in lane 4 for EG7283, a crystal protein having a mass of approximately 130 kDa was produced. The wild type strain EG5847 exhibited a large protein band of approximately 130 kDa. The observed masses of the crystal proteins are in agreement with the masses predicted from the DNA sequences obtained in Example 3.
EXAMPLE 2
Cloning of the cryET4 and cryET5 Genes
Genomic DNA was isolated from B.t. strain EG5847 and then digested with HindIII. cryI-like genes were identified by Southern blotting (described by Southern, J. Mol. Biol. 98, pp. 503-517 (1975)). A radiolabelled 700 bp EcoR1 fragment of the cryIA(a) gene (described by Schnepf et al., J. Biol. Chem., 260, pp. 6264-6272 (1985)) was used as a hybridization probe to identify cryI-like genes containing HindIII restriction fragments of EG5847 DNA. The 700 bp cryIA(a) fragment hybridized to several HindIII restriction fragments of EG5847 DNA including fragments of approximately 5.0 kb and 4.7 kb.
The 5.0 kb and 4.7 kb cryIA(a)-hybridizing HindIII restriction fragments of B.t. strain EG5847 were cloned as follows. DNA fragments of approximately 4-8 kb from HindIII digests of EG5847 genomic DNA were purified by agarose gel electrophoresis and electroelution. These fragments were ligated to the E. coli plasmid vector pUC18 and the ligation mixture was then used to transform E. coli. Ampicillin-resistant E. coli colonies were blotted to nitrocellulose filters (Grunstein et al., Proc. Natl. Acad. Sci. USA 72, pp. 3961-3965 (1975)). The filters were probed with the radiolabelled 700 bp cryIA(a) gene fragment. Two positive colonies, designated as E. coli strains EG7286 and EG7287, were identified and were selected for further analysis.
HindIII digestion of a plasmid, designated pEG291, isolated from E. coli strain EG7286 revealed a HindIII insert fragment 5.0 kb in size in pUC18. The restriction map of plasmid pEG291 is shown in FIG. 5A.
An E. coli/B. thuringiensis shuttle vector containing the 5.0 kb HindIII fragment was constructed by ligating BamHI digested Bacillus plasmid pNN101 (Norton et al., Plasmid, 13, pp. 211-214 (1985)) into the unique BamHI site of pEG291 (FIG. 5B). The resulting plasmid, designated pEG1108 (FIG. 5B), contains a full length open reading frame which has been designated as the cryET4 gene (SEQ ID NO:1).
E. coli strain EG7287 contained a plasmid, designated pEG292, which had a 4.7 kb HindIII insert in pUC18. DNA sequencing as described in Example 3 indicated that an open reading frame present in the 4.7 kb insert was truncated at its 3'-end (FIG. 6A). The truncated portion was isolated using a synthetic oligonucleotide having the sequence 5'-AAGTTTCGCATCCATCGATG-3' (SEQ ID NO:5). The oligonucleotide, designated WD162, was homologous to nucleotides 2253 to 2272 of the open reading frame identified in plasmid pEG292. Southern blot analyses as described above indicated that WD162 (SEQ ID NO:5) hybridized to a 3.2 kb HincII restriction fragment of EG5847 DNA. Radiolabelled WD162 was then used in colony blot experiments as described above to probe E. coli cells that contained a plasmid library consisting of size-selected HincII restriction fragments of EG5847 DNA. Several E. coli colonies hybridized with WD162 and one colony, designated E. coli strain EG7288, was selected for further analysis.
HincII restriction analysis of a recombinant plasmid, designated pEG300, isolated from E. coli EG7288, indicated that a 3.9 kb HincII fragment was present in pUC18. DNA sequencing as described below showed that pEG300 contained an open reading frame truncated at its 5'-end by the HincII cleavage site (FIG. 6B).
The full length open reading frame was constructed by excising a 2.6 kb XbaI-BsmI fragment containing the 5' portion of the open reading frame from plasmid pEG292 and inserting the fragment into the XbaI-BsmI restriction sites of plasmid pEG300 (FIG. 6A and 6B). The resulting plasmid, designated pEG1110 (FIG. 6C), contains a full length open reading frame which has been designated as the cryET5 gene (SEQ ID NO:3).
An E. coli/B. thuringiensis expression vector containing the full length open reading frame of the cryET5 gene was constructed by ligating XbaI digested Bacillus plasmid pNN101 (Norton, supra) into the unique XbaI site of plasmid pEG1110 (FIG. 6D). The resulting construct was designated plasmid pEG1111.
Plasmids pEG1108 and pEG1111 are capable of replicating in both E. coli and B.t. The plasmids were transformed by electroporation (Macaluso et al., J. Bacteriol., 173, pp. 1353-1356 (1991)) into the acrystalliferous B.t. strain EG10368 resulting in B.t. strains EG7279(pEG1108) and EG7283(pEG1111), respectively containing the cryET4 and cryET5 genes. Both of these B.t. strains are capable of expressing their respective protein toxin genes, as described in Example 4.
EXAMPLE 3
Sequencing of the cryET4 and cryET5 Genes
The complete DNA sequence of the cryET4 gene was determined using plasmid pEG291 (Example 2). Plasmid pEG291 was sequenced by standard methods (Sanger et al., Proc. Natl. Acad. Sci. USA, 74, pp. 5463-5467 (1977)). The DNA sequences of the appropriate subclones of the 5.0 kb HindIII fragment were joined to give a continuous sequence of 3713 nucleotides which is shown in FIG. 1 and is designated as SEQ ID NO:1. Inspection of the sequence revealed an open reading frame beginning at position 99 and extending to position 3602 (including the stop codon). The gene has been designated cryET4. The deduced 1167 amino acid sequence of the gene product is shown in FIG. 1 and is designated as SEQ ID NO:2. The mass of the CryET4 protein (SEQ ID NO:2) encoded by the cryET4 gene (SEQ ID NO:1), as deduced from the open reading frame, is 132,774 Da. Among CryI-type protein toxins reported in the literature, the CryIA(a) protein appears to be most closely related to the CryET4 protein. CryET4 exhibits 69% amino acid homology with CryIA(a).
The complete DNA sequence of the cryET5 gene (SEQ ID NO:3) was determined by the Sanger method as described above. Subcloned gene fragments from pEG292, pEG300 and pEG1110 were sequenced. The DNA sequences of the subcloned fragments were joined to give a continuous sequence of 3,934 nucleotides which is shown in FIG. 2 and is designated as SEQ ID NO:3. Inspection of the sequence revealed an open reading frame beginning at position 67 and extending to position 3756 (including the stop codon). The gene has been designated cryET5. The deduced 1229 amino acid sequence of the gene product encoded by the cryET5 gene (SEQ ID NO:3) is shown in FIG. 2 and is designated as SEQ ID NO:4. The mass of the CryET5 protein (SEQ ID NO:4) encoded by the cryET5 gene (SEQ ID NO:3), as deduced from the open reading frame, is 139,783 Da. Among CryI-type proteins reported in the literature, the CryIB protein appears to be most closely related to the CryET5 protein. CryET5 exhibits 83% amino acid homology with CryIB.
EXAMPLE 4
Insecticidal Activity of Recombinant Strains Harboring cryET4 and cryET5 Genes
PLC.sub.50 values of purified CryET4 and CryET5 crystal proteins were determined against lepidopteran insects, and these are listed in Tables 1 and 2, respectively. The PLC.sub.50 dose is that amount of insecticidal crystal protein (ICP) which killed half of the insects tested, i.e., the median lethal concentration. CryET4 and CryET5 crystal proteins were isolated from B.t. strains EG7279 and EG7283, respectively, (described in Example 2) by sucrose density gradient centrifugation as described above. The amount of crystal protein recovered from the gradients was quantified by the Bradford protein assay (Bradford, Anal. Biochem., 72, p. 248 (1976)) after solubilization of the recovered crystal proteins with base and a reducing agent. Known amounts of purified crystals were diluted in 0.005% Triton.RTM. X-100 (v/v). Aliquots of eight two-fold serial dilutions (50 .mu.l) were applied to the surfaces of 32 wells (1.8 cm.sup.2 surface area) containing insect diet and dried for 1 hour at 30.degree. C. A general purpose Noctuidae artificial diet (E. G. King et al., Handbook of Insect Rearing, Vol. 2, P. Singh and R. F. Moore (eds.), pp. 323-328, Elsevier Science Publishers B. V., Amsterdam (1985)) was used for Trichoplusia ni, Ostrinia nubilalis and Heliothis virescens. Other standard diets were used for the other lepidopteran insects tested. One neonate larva (third-instar larva in the case of P. xylostella) was added to each well, and the wells were incubated at 30.degree. C. Mortality was recorded after seven days.
The insecticidal activity of CryET4 protein was compared with the activity of CryIA(a) protein (Schnepf et al., J. Biol. Chem., 260, pp. 6264-6272 (1985)). CryET4 exhibits a 69% amino acid sequence homology with CryIA(a). The results are presented in Table 1.
TABLE 1______________________________________PLC.sub.50 Bioassay Activity of Purified CryET4 PLC.sub.50 (ng ICP/well)Insect Species CryET4 CryIA(a)______________________________________Heliothis virescens 593 (493-711)** 94 (76-113)Helicoverpa zea 1,290 (1,046-1,599) 3,725 (3,004-4,551)Lymantria dispar 9,929 (5,767-26,039) 185 (138-243)Ostrinia nubilalis 197 (121-299) 34 (27-42)Pseudoplusia includens 33 (29-37) 14 (12-16)Plutella xylosella 30 (22-41) 12 (10-14)Javelin .RTM.*-resistant 4,758 (3,135-6,697) >50,000P. xylostellaSpodoptera exiqua 1,748 (1,286-2,591) >20,000Spodoptera frugiperda 1,161 (555-2,115) >10,000Trichoplusia ni 62 (53-74) 80 (54-113)______________________________________ *Javelin is a commercial B.t. bioinsecticide. **Range in parentheses indicates 95% confidence level.
The PLC.sub.50 results in Table 1 indicate that the CryET4 protein (SEQ ID NO:2) exhibits good insecticidal activity to a broad spectrum of lepidopteran insects.
The results show that the CryET4 protein is more toxic than CryIA(a) against Helicoverpa zea (corn earworm/bollworm), Javelin.RTM.-resistant Plutella xylostella (diamondback moth), Spodoptera exigua (beet armyworm) and Spodoptera frugiperda (fall armyworm).
Particularly noteworthy is the very good activity against Spodoptera exigua (beet armyworm), an insect pest that not only is not susceptible to CryIA(a), but also is recalcitrant to most B.t. toxin proteins, and very good activity against Spodoptera frugiperda (fall armyworm), another recalcitrant insect pest. Activity against Pseudoplusia includens (soybean looper), Plutella xylostella (diamondback moth) and Trichoplusia ni (cabbage looper) was also good, comparable to that exhibited by CryIA(a).
Insect bioassay tests with CryET4 protein were also carried out against another lepidopteran insect, Agrotis ipsilon (black cutworm), which was found not to be susceptible to control with CryET4.
The insecticidal activity of CryET5 protein was compared with the activity of CryIB protein (Brizzard et al., Nucleic Acids Res. 16, 2723-2724 (1988)). CryET5 exhibits an 83% amino acid sequence homology with CryIB. Dilutions of purified CryET5 crystals were prepared in 0.005% Triton.RTM. X-100. Aliquots of appropriate dilutions (50 .mu.l) were applied to the surfaces of 32 wells and assayed as indicated above. The results are presented in Table 2.
TABLE 2______________________________________PLC.sub.50 Bioassay Activity of Purified CryET5 PLC.sub.50 (ng ICP/well)Insect Species CryET5 CryIB______________________________________Lymantria dispar 880 (555-1,397)** 3,580 (1,293-20,123)Ostrinia nubilalis 32 (29-37) 83 (51-123)Pseudoplusia includens 555 (437-646) 52 (44-61)Piutella xylostella 157 (127-193) 27 (23-32)Javelin .RTM.*-resistantP. xylostella 47 (23-80) 43 (35-55)Spodoptera frugiperda 2,612 (1,831-4,514) >10,000Tricnoplusia ni 22 (19-27) 205 (176-241)______________________________________ *Javelin is a commercial B.t. bioinsecticide. **Range in parentheses indicates 95% confidence level.
The PLC.sub.50 results in Table 2 indicate that the CryET5 protein (SEQ ID NO:4) exhibits good insecticidal activity to a broad spectrum of lepidopteran insects.
The results show that the CryET5 protein is more toxic than CryIB against Spodoptera frugiperda (fall armyworm) and Trichoplusia ni (cabbage looper). The CryET5 protein and CryIB protein both exhibited excellent insecticidal activity against Javelin.RTM.-resistant Flutella xylostella (diamondback moth), a B.t.-resistant insect pest that is not susceptible to CryIA-type toxin proteins, and to Ostrinia nubilalis (European corn borer).
Insect bioassay tests with CryET5 protein were also carried out against a few other lepidopteran insects, but these were found not to be susceptible to control with CryET5: Agrotis ipsilon (black cutworm), Heliothis virescens (tobacco budworm), Helicoverpa zea (corn earworm/bollworm) and Spodoptera exigua (beet armyworm).
The present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof and, accordingly, reference should be made to the appended claims, rather than to the foregoing specification as indicating the scope of the invention.
__________________________________________________________________________# SEQUENCE LISTING- (1) GENERAL INFORMATION:- (iii) NUMBER OF SEQUENCES: 5- (2) INFORMATION FOR SEQ ID NO:1:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 3713 base (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: circular- (ii) MOLECULE TYPE: DNA (genomic)- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 99..3602- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:- AAATTCATAA TATGAATCAT ACGTTTTAAA GTGTTGTGAA GAAAAGAGAA TT - #GATCTTTA 60#AAT AAT 113ACCA AAGAGAAAGG GGTAACTT ATG GAG ATA# Met Glu Ile Asn Asn# 5 1- CAG AAG CAA TGC ATA CCA TAT AAT TGC TTA AG - #T AAT CCT GAG GAA GTA 161Gln Lys Gln Cys Ile Pro Tyr Asn Cys Leu Se - #r Asn Pro Glu Glu Val# 20- CTT TTG GAT GGG GAG AGG ATA TTA CCT GAT AT - #C GAT CCA CTC GAA GTT 209Leu Leu Asp Gly Glu Arg Ile Leu Pro Asp Il - #e Asp Pro Leu Glu Val# 35- TCT TTG TCG CTT TTG CAA TTT CTT TTG AAT AA - #C TTT GTT CCA GGG GGA 257Ser Leu Ser Leu Leu Gln Phe Leu Leu Asn As - #n Phe Val Pro Gly Gly# 50- GGC TTT ATT TCA GGA TTA GTT GAT AAA ATA TG - #G GGG GCT TTG AGA CCA 305Gly Phe Ile Ser Gly Leu Val Asp Lys Ile Tr - #p Gly Ala Leu Arg Pro# 65- TCT GAA TGG GAC TTA TTT CTT GCA CAG ATT GA - #A CGG TTG ATT GAT CAA 353Ser Glu Trp Asp Leu Phe Leu Ala Gln Ile Gl - #u Arg Leu Ile Asp Gln# 85- AGA ATA GAA GCA ACA GTA AGA GCA AAA GCA AT - #C ACT GAA TTA GAA GGA 401Arg Ile Glu Ala Thr Val Arg Ala Lys Ala Il - #e Thr Glu Leu Glu Gly# 100- TTA GGG AGA AAT TAT CAA ATA TAC GCT GAA GC - #A TTT AAA GAA TGG GAA 449Leu Gly Arg Asn Tyr Gln Ile Tyr Ala Glu Al - #a Phe Lys Glu Trp Glu# 115- TCA GAT CCT GAT AAC GAA GCG GCT AAA AGT AG - #A GTA ATT GAT CGC TTT 497Ser Asp Pro Asp Asn Glu Ala Ala Lys Ser Ar - #g Val Ile Asp Arg Phe# 130- CGT ATA CTT GAT GGT CTA ATT GAA GCA AAT AT - #C CCT TCA TTT CGG ATA 545Arg Ile Leu Asp Gly Leu Ile Glu Ala Asn Il - #e Pro Ser Phe Arg Ile# 145- ATT GGA TTT GAA GTG CCA CTT TTA TCG GTT TA - #T GTT CAA GCA GCT AAT 593Ile Gly Phe Glu Val Pro Leu Leu Ser Val Ty - #r Val Gln Ala Ala Asn150 1 - #55 1 - #60 1 -#65- CTA CAT CTC GCT CTA TTG AGA GAT TCT GTT AT - #T TTT GGA GAG AGA TGG 641Leu His Leu Ala Leu Leu Arg Asp Ser Val Il - #e Phe Gly Glu Arg Trp# 180- GGA TTG ACG ACA AAA AAT GTC AAT GAT ATC TA - #T AAT AGA CAA ATT AGA 689Gly Leu Thr Thr Lys Asn Val Asn Asp Ile Ty - #r Asn Arg Gln Ile Arg# 195- GAA ATT CAT GAA TAT AGC AAT CAT TGC GTA GA - #T ACG TAT AAC ACA GAA 737Glu Ile His Glu Tyr Ser Asn His Cys Val As - #p Thr Tyr Asn Thr Glu# 210- CTA GAA CGT CTA GGG TTT AGA TCT ATA GCG CA - #G TGG AGA ATA TAT AAT 785Leu Glu Arg Leu Gly Phe Arg Ser Ile Ala Gl - #n Trp Arg Ile Tyr Asn# 225- CAG TTT AGA AGA GAA CTA ACA CTA ACT GTA TT - #A GAT ATT GTC GCT CTT 833Gln Phe Arg Arg Glu Leu Thr Leu Thr Val Le - #u Asp Ile Val Ala Leu230 2 - #35 2 - #40 2 -#45- TTC CCG AAC TAT GAC AGT AGA CTG TAT CCG AT - #C CAA ACT TTT TCT CAA 881Phe Pro Asn Tyr Asp Ser Arg Leu Tyr Pro Il - #e Gln Thr Phe Ser Gln# 260- TTG ACA AGA GAA ATT GTT ACA TCC CCA GTA AG - #C GAA TTT TAT TAT GGT 929Leu Thr Arg Glu Ile Val Thr Ser Pro Val Se - #r Glu Phe Tyr Tyr Gly# 275- GTT ATT AAT AGT GGT AAT ATA ATT GGT ACT CT - #T ACT GAA CAG CAG ATA 977Val Ile Asn Ser Gly Asn Ile Ile Gly Thr Le - #u Thr Glu Gln Gln Ile# 290- AGG CGA CCA CAT CTT ATG GAC TTC TTT AAC TC - #C ATG ATC ATG TAT ACA1025Arg Arg Pro His Leu Met Asp Phe Phe Asn Se - #r Met Ile Met Tyr Thr# 305- TCA GAT AAT AGA CGG GAA CAT TAT TGG TCA GG - #A CTT GAA ATG ACG GCT1073Ser Asp Asn Arg Arg Glu His Tyr Trp Ser Gl - #y Leu Glu Met Thr Ala310 3 - #15 3 - #20 3 -#25- TAT TTT ACA GGA TTT GCA GGA GCT CAA GTG TC - #A TTC CCT TTA GTC GGG1121Tyr Phe Thr Gly Phe Ala Gly Ala Gln Val Se - #r Phe Pro Leu Val Gly# 340- ACT AGA GGG GAG TCA GCT CCA CCA TTA ACT GT - #T AGA AGT GTT AAT GAT1169Thr Arg Gly Glu Ser Ala Pro Pro Leu Thr Va - #l Arg Ser Val Asn Asp# 355- GGA ATT TAT AGA ATA TTA TCG GCA CCG TTT TA - #T TCA GCG CCT TTT CTA1217Gly Ile Tyr Arg Ile Leu Ser Ala Pro Phe Ty - #r Ser Ala Pro Phe Leu# 370- GGC ACC ATT GTA TTG GGA AGT CGT GGA GAA AA - #A TTT GAT TTT GCG CTT1265Gly Thr Ile Val Leu Gly Ser Arg Gly Glu Ly - #s Phe Asp Phe Ala Leu# 385- AAT AAT ATT TCA CCT CCG CCA TCT ACA ATA TA - #C AGA CAT CCT GGA ACA1313Asn Asn Ile Ser Pro Pro Pro Ser Thr Ile Ty - #r Arg His Pro Gly Thr390 3 - #95 4 - #00 4 -#05- GTA GAT TCA CTA GTC AGT ATA CCG CCA CAG GA - #T AAT AGC GTA CCA CCG1361Val Asp Ser Leu Val Ser Ile Pro Pro Gln As - #p Asn Ser Val Pro Pro# 420- CAC AGG GGA TCT AGT CAT CGA TTA AGT CAT GT - #T ACA ATG CGC GCA AGT1409His Arg Gly Ser Ser His Arg Leu Ser His Va - #l Thr Met Arg Ala Ser# 435- TCC CCT ATA TTC CAT TGG ACG CAT CGC AGC GC - #A ACC ACT ACA AAT ACA1457Ser Pro Ile Phe His Trp Thr His Arg Ser Al - #a Thr Thr Thr Asn Thr# 450- ATT AAT CCA AAT GCT ATT ATC CAA ATA CCA CT - #A GTA AAA GCA TTT AAC1505Ile Asn Pro Asn Ala Ile Ile Gln Ile Pro Le - #u Val Lys Ala Phe Asn# 465- CTT CAT TCA GGT GCC ACT GTT GTT AGA GGA CC - #A GGG TTT ACA GGT GGT1553Leu His Ser Gly Ala Thr Val Val Arg Gly Pr - #o Gly Phe Thr Gly Gly470 4 - #75 4 - #80 4 -#85- GAT ATC CTT CGA AGA ACG AAT ACT GGC ACA TT - #T GCA GAT ATG AGA GTA1601Asp Ile Leu Arg Arg Thr Asn Thr Gly Thr Ph - #e Ala Asp Met Arg Val# 500- AAT ATT ACT GGG CCA TTA TCC CAA AGA TAT CG - #T GTA AGA ATT CGC TAT1649Asn Ile Thr Gly Pro Leu Ser Gln Arg Tyr Ar - #g Val Arg Ile Arg Tyr# 515- GCT TCT ACG ACA GAT TTA CAA TTT TTC ACG AG - #A ATC AAT GGA ACT TCT1697Ala Ser Thr Thr Asp Leu Gln Phe Phe Thr Ar - #g Ile Asn Gly Thr Ser# 530- GTA AAT CAA GGT AAT TTC CAA AGA ACT ATG AA - #T AGA GGG GAT AAT TTA1745Val Asn Gln Gly Asn Phe Gln Arg Thr Met As - #n Arg Gly Asp Asn Leu# 545- GAA TCT GGA AAC TTT AGG ACT GCA GGA TTT AG - #T ACG CCT TTT AGT TTT1793Glu Ser Gly Asn Phe Arg Thr Ala Gly Phe Se - #r Thr Pro Phe Ser Phe550 5 - #55 5 - #60 5 -#65- TCA AAT GCG CAA AGT ACA TTC ACA TTG GGT AC - #T CAG GCT TTT TCA AAT1841Ser Asn Ala Gln Ser Thr Phe Thr Leu Gly Th - #r Gln Ala Phe Ser Asn# 580- CAG GAA GTT TAT ATA GAT CGA ATT GAA TTT GT - #C CCG GCA GAA GTA ACA1889Gln Glu Val Tyr Ile Asp Arg Ile Glu Phe Va - #l Pro Ala Glu Val Thr# 595- TTC GAG GCA GAA TCT GAT TTA GAA AGA GCG CA - #A AAG GCG GTG AAT GCC1937Phe Glu Ala Glu Ser Asp Leu Glu Arg Ala Gl - #n Lys Ala Val Asn Ala# 610- CTG TTT ACT TCT ACA AAC CAA CTA GGG CTA AA - #A ACA GAT GTG ACG GAT1985Leu Phe Thr Ser Thr Asn Gln Leu Gly Leu Ly - #s Thr Asp Val Thr Asp# 625- TAT CAG ATT GAT CAA GTG TCC AAT TTA GTA GA - #A TGT TTA TCA GAT GAA2033Tyr Gln Ile Asp Gln Val Ser Asn Leu Val Gl - #u Cys Leu Ser Asp Glu630 6 - #35 6 - #40 6 -#45- TTT TGT CTG GAT GAA AAG AGA GAA TTG TCC GA - #G AAA GTC AAA CAT GCA2081Phe Cys Leu Asp Glu Lys Arg Glu Leu Ser Gl - #u Lys Val Lys His Ala# 660- AAG CGA CTT AGT GAT AAG CGG AAC CTA CTT CA - #A GAT CCA AAC TTC ACA2129Lys Arg Leu Ser Asp Lys Arg Asn Leu Leu Gl - #n Asp Pro Asn Phe Thr# 675- TCT ATC AAT AGA CAA CTA GAC CGT GGA TGG AG - #A GGA AGT ACG GAT ATT2177Ser Ile Asn Arg Gln Leu Asp Arg Gly Trp Ar - #g Gly Ser Thr Asp Ile# 690- ACC ATC CAA GGA GGA AAT GAC GTA TTC AAA GA - #G AAT TAC GTC ACA CTA2225Thr Ile Gln Gly Gly Asn Asp Val Phe Lys Gl - #u Asn Tyr Val Thr Leu# 705- CCA GGT ACC TTT GAT GAG TGT TAT CCA ACG TA - #T TTG TAT CAA AAA ATA2273Pro Gly Thr Phe Asp Glu Cys Tyr Pro Thr Ty - #r Leu Tyr Gln Lys Ile710 7 - #15 7 - #20 7 -#25- GAT GAG TCA AAA TTA AAA GCC TAT ACT CGC TA - #T GAA TTA AGA GGG TAT2321Asp Glu Ser Lys Leu Lys Ala Tyr Thr Arg Ty - #r Glu Leu Arg Gly Tyr# 740- ATT GAA GAT AGT CAA GAT TTA GAA GTC TAT TT - #G ATT CGT TAC AAT GCG2369Ile Glu Asp Ser Gln Asp Leu Glu Val Tyr Le - #u Ile Arg Tyr Asn Ala# 755- AAA CAT GAA ACA GTA AAT GTT CCC GGT ACA GG - #G TCC TTA TGG CCG CTT2417Lys His Glu Thr Val Asn Val Pro Gly Thr Gl - #y Ser Leu Trp Pro Leu# 770- TCA GTC GAA AGC CCA ATC GGA AGG TGC GGA GA - #A CCG AAT CGA TGT GTG2465Ser Val Glu Ser Pro Ile Gly Arg Cys Gly Gl - #u Pro Asn Arg Cys Val# 785- CCA CAT ATT GAA TGG AAT CCT GAT TTA GAT TG - #T TCG TGT AGG GAT GGG2513Pro His Ile Glu Trp Asn Pro Asp Leu Asp Cy - #s Ser Cys Arg Asp Gly790 7 - #95 8 - #00 8 -#05- GAG AAG TGT GCC CAT CAT TCG CAT CAT TTC TC - #T CTA GAT ATT GAT GTT2561Glu Lys Cys Ala His His Ser His His Phe Se - #r Leu Asp Ile Asp Val# 820- GGA TGT ACA GAC CTA AAT GAG GAC CTA GGT GT - #A TGG GTG ATC TTT AAG2609Gly Cys Thr Asp Leu Asn Glu Asp Leu Gly Va - #l Trp Val Ile Phe Lys# 835- ATT AAA ACG CAG GAT GGC CAT GCA AGA TTA GG - #A AAT CTA GAG TTT CTC2657Ile Lys Thr Gln Asp Gly His Ala Arg Leu Gl - #y Asn Leu Glu Phe Leu# 850- GAA GAG AAA CCA TTG TTA GGA GAA GCG TTA GC - #T CGT GTG AAA AGA GCG2705Glu Glu Lys Pro Leu Leu Gly Glu Ala Leu Al - #a Arg Val Lys Arg Ala# 865- GAG AAA AAA TGG AGA GAC AAA CGC GAA CAA TT - #G CAG TTT GAA ACG AAT2753Glu Lys Lys Trp Arg Asp Lys Arg Glu Gln Le - #u Gln Phe Glu Thr Asn870 8 - #75 8 - #80 8 -#85- ATC GTT TAC AAA GAG GCA AAA GAA TCT GTA GA - #T GCT TTA TTC GTA GAT2801Ile Val Tyr Lys Glu Ala Lys Glu Ser Val As - #p Ala Leu Phe Val Asp# 900- TCT CAC TAT AAT AGA TTA CAA GCG GAT ACG AA - #C ATT ACG ATG ATT CAT2849Ser His Tyr Asn Arg Leu Gln Ala Asp Thr As - #n Ile Thr Met Ile His# 915- GCG GCA GAT AAA CGC GTT CAT CGA ATC CGA GA - #G GCT TAT CTT CCG GAA2897Ala Ala Asp Lys Arg Val His Arg Ile Arg Gl - #u Ala Tyr Leu Pro Glu# 930- TTA TCC GTT ATC CCA GGT GTA AAT GCG GAC AT - #T TTT GAA GAA TTA GAA2945Leu Ser Val Ile Pro Gly Val Asn Ala Asp Il - #e Phe Glu Glu Leu Glu# 945- GGT CTT ATT TTC ACT GCA TTC TCC CTA TAT GA - #T GCG AGA AAT ATC ATT2993Gly Leu Ile Phe Thr Ala Phe Ser Leu Tyr As - #p Ala Arg Asn Ile Ile950 9 - #55 9 - #60 9 -#65- AAA AAC GGT GAT TTC AAT AAT GGT TTA TCG TG - #T TGG AAC GTG AAA GGG3041Lys Asn Gly Asp Phe Asn Asn Gly Leu Ser Cy - #s Trp Asn Val Lys Gly# 980- CAT GTA GAT ATA CAA CAG AAT GAT CAT CGT TC - #T GTC CTC GTT GTC CCG3089His Val Asp Ile Gln Gln Asn Asp His Arg Se - #r Val Leu Val Val Pro# 995- GAA TGG GAA TCA GAG GTA TCA CAA GAA GTC CG - #C GTA TGT CCA GGT CGT3137Glu Trp Glu Ser Glu Val Ser Gln Glu Val Ar - #g Val Cys Pro Gly Arg# 10105- GGC TAT ATT CTT CGT GTC ACA GCG TAC AAA GA - #G GGC TAC GGA GAA GGA3185Gly Tyr Ile Leu Arg Val Thr Ala Tyr Lys Gl - #u Gly Tyr Gly Glu Gly# 10250- TGC GTA ACG ATC CAT GAG ATC GAA GAC AAT AC - #A GAC GAA TTG AAG TTT3233Cys Val Thr Ile His Glu Ile Glu Asp Asn Th - #r Asp Glu Leu Lys Phe# 10451035 - # 1040- AGT AAC TGC ATA GAA GAG GAA GTC TAT CCA AC - #G GAT ACA GGT AAT GAT3281Ser Asn Cys Ile Glu Glu Glu Val Tyr Pro Th - #r Asp Thr Gly Asn Asp# 10605- TAT ACT GCA CAC CAA GGT ACA ACA GGA TGC GC - #A GAT GCA TGT AAT TCC3329Tyr Thr Ala His Gln Gly Thr Thr Gly Cys Al - #a Asp Ala Cys Asn Ser# 10750- CGT AAT GTT GGA TAT GAG GAT GGA TAT GAA AT - #A AAT ACT ACA GCA TCT3377Arg Asn Val Gly Tyr Glu Asp Gly Tyr Glu Il - #e Asn Thr Thr Ala Ser# 10905- GTT AAT TAC AAA CCG ACT TAT GAA GAA GAA AT - #G TAT ACA GAT GTA CGA3425Val Asn Tyr Lys Pro Thr Tyr Glu Glu Glu Me - #t Tyr Thr Asp Val Arg# 11050- AGA GAT AAT CAT TGT GAA TAT GAC AGA GGA TA - #T GGG AAC CAT ACA CCG3473Arg Asp Asn His Cys Glu Tyr Asp Arg Gly Ty - #r Gly Asn His Thr Pro# 11251115 - # 1120- TTA CCA GCT GGT TAT GTA ACA AAA GAA TTA GA - #G TAC TTC CCT GAA ACA3521Leu Pro Ala Gly Tyr Val Thr Lys Glu Leu Gl - #u Tyr Phe Pro Glu Thr# 11405- GAT ACA GTA TGG ATA GAG ATT GGA GAA ACG GA - #A GGA ACA TTC ATC GTA3569Asp Thr Val Trp Ile Glu Ile Gly Glu Thr Gl - #u Gly Thr Phe Ile Val# 11550- GAT AGT GTG GAA TTA CTC CTC ATG GAG GAA TA - #AGATTGTA CGAAATCGAC3619Asp Ser Val Glu Leu Leu Leu Met Glu Glu# 1165- TTTAAATGGC TCATTCTAAA CAAAAAGTAG TCGTCTAATC TCTGTAACAA AT - #AGAAAAGT3679# 3713 AAGA AAAAGGACAT TACT- (2) INFORMATION FOR SEQ ID NO:2:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 1167 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:- Met Glu Ile Asn Asn Gln Lys Gln Cys Ile Pr - #o Tyr Asn Cys Leu Ser# 15- Asn Pro Glu Glu Val Leu Leu Asp Gly Glu Ar - #g Ile Leu Pro Asp Ile# 30- Asp Pro Leu Glu Val Ser Leu Ser Leu Leu Gl - #n Phe Leu Leu Asn Asn# 45- Phe Val Pro Gly Gly Gly Phe Ile Ser Gly Le - #u Val Asp Lys Ile Trp# 60- Gly Ala Leu Arg Pro Ser Glu Trp Asp Leu Ph - #e Leu Ala Gln Ile Glu# 80- Arg Leu Ile Asp Gln Arg Ile Glu Ala Thr Va - #l Arg Ala Lys Ala Ile# 95- Thr Glu Leu Glu Gly Leu Gly Arg Asn Tyr Gl - #n Ile Tyr Ala Glu Ala# 110- Phe Lys Glu Trp Glu Ser Asp Pro Asp Asn Gl - #u Ala Ala Lys Ser Arg# 125- Val Ile Asp Arg Phe Arg Ile Leu Asp Gly Le - #u Ile Glu Ala Asn Ile# 140- Pro Ser Phe Arg Ile Ile Gly Phe Glu Val Pr - #o Leu Leu Ser Val Tyr145 1 - #50 1 - #55 1 -#60- Val Gln Ala Ala Asn Leu His Leu Ala Leu Le - #u Arg Asp Ser Val Ile# 175- Phe Gly Glu Arg Trp Gly Leu Thr Thr Lys As - #n Val Asn Asp Ile Tyr# 190- Asn Arg Gln Ile Arg Glu Ile His Glu Tyr Se - #r Asn His Cys Val Asp# 205- Thr Tyr Asn Thr Glu Leu Glu Arg Leu Gly Ph - #e Arg Ser Ile Ala Gln# 220- Trp Arg Ile Tyr Asn Gln Phe Arg Arg Glu Le - #u Thr Leu Thr Val Leu225 2 - #30 2 - #35 2 -#40- Asp Ile Val Ala Leu Phe Pro Asn Tyr Asp Se - #r Arg Leu Tyr Pro Ile# 255- Gln Thr Phe Ser Gln Leu Thr Arg Glu Ile Va - #l Thr Ser Pro Val Ser# 270- Glu Phe Tyr Tyr Gly Val Ile Asn Ser Gly As - #n Ile Ile Gly Thr Leu# 285- Thr Glu Gln Gln Ile Arg Arg Pro His Leu Me - #t Asp Phe Phe Asn Ser# 300- Met Ile Met Tyr Thr Ser Asp Asn Arg Arg Gl - #u His Tyr Trp Ser Gly305 3 - #10 3 - #15 3 -#20- Leu Glu Met Thr Ala Tyr Phe Thr Gly Phe Al - #a Gly Ala Gln Val Ser# 335- Phe Pro Leu Val Gly Thr Arg Gly Glu Ser Al - #a Pro Pro Leu Thr Val# 350- Arg Ser Val Asn Asp Gly Ile Tyr Arg Ile Le - #u Ser Ala Pro Phe Tyr# 365- Ser Ala Pro Phe Leu Gly Thr Ile Val Leu Gl - #y Ser Arg Gly Glu Lys# 380- Phe Asp Phe Ala Leu Asn Asn Ile Ser Pro Pr - #o Pro Ser Thr Ile Tyr385 3 - #90 3 - #95 4 -#00- Arg His Pro Gly Thr Val Asp Ser Leu Val Se - #r Ile Pro Pro Gln Asp# 415- Asn Ser Val Pro Pro His Arg Gly Ser Ser Hi - #s Arg Leu Ser His Val# 430- Thr Met Arg Ala Ser Ser Pro Ile Phe His Tr - #p Thr His Arg Ser Ala# 445- Thr Thr Thr Asn Thr Ile Asn Pro Asn Ala Il - #e Ile Gln Ile Pro Leu# 460- Val Lys Ala Phe Asn Leu His Ser Gly Ala Th - #r Val Val Arg Gly Pro465 4 - #70 4 - #75 4 -#80- Gly Phe Thr Gly Gly Asp Ile Leu Arg Arg Th - #r Asn Thr Gly Thr Phe# 495- Ala Asp Met Arg Val Asn Ile Thr Gly Pro Le - #u Ser Gln Arg Tyr Arg# 510- Val Arg Ile Arg Tyr Ala Ser Thr Thr Asp Le - #u Gln Phe Phe Thr Arg# 525- Ile Asn Gly Thr Ser Val Asn Gln Gly Asn Ph - #e Gln Arg Thr Met Asn# 540- Arg Gly Asp Asn Leu Glu Ser Gly Asn Phe Ar - #g Thr Ala Gly Phe Ser545 5 - #50 5 - #55 5 -#60- Thr Pro Phe Ser Phe Ser Asn Ala Gln Ser Th - #r Phe Thr Leu Gly Thr# 575- Gln Ala Phe Ser Asn Gln Glu Val Tyr Ile As - #p Arg Ile Glu Phe Val# 590- Pro Ala Glu Val Thr Phe Glu Ala Glu Ser As - #p Leu Glu Arg Ala Gln# 605- Lys Ala Val Asn Ala Leu Phe Thr Ser Thr As - #n Gln Leu Gly Leu Lys# 620- Thr Asp Val Thr Asp Tyr Gln Ile Asp Gln Va - #l Ser Asn Leu Val Glu625 6 - #30 6 - #35 6 -#40- Cys Leu Ser Asp Glu Phe Cys Leu Asp Glu Ly - #s Arg Glu Leu Ser Glu# 655- Lys Val Lys His Ala Lys Arg Leu Ser Asp Ly - #s Arg Asn Leu Leu Gln# 670- Asp Pro Asn Phe Thr Ser Ile Asn Arg Gln Le - #u Asp Arg Gly Trp Arg# 685- Gly Ser Thr Asp Ile Thr Ile Gln Gly Gly As - #n Asp Val Phe Lys Glu# 700- Asn Tyr Val Thr Leu Pro Gly Thr Phe Asp Gl - #u Cys Tyr Pro Thr Tyr705 7 - #10 7 - #15 7 -#20- Leu Tyr Gln Lys Ile Asp Glu Ser Lys Leu Ly - #s Ala Tyr Thr Arg Tyr# 735- Glu Leu Arg Gly Tyr Ile Glu Asp Ser Gln As - #p Leu Glu Val Tyr Leu# 750- Ile Arg Tyr Asn Ala Lys His Glu Thr Val As - #n Val Pro Gly Thr Gly# 765- Ser Leu Trp Pro Leu Ser Val Glu Ser Pro Il - #e Gly Arg Cys Gly Glu# 780- Pro Asn Arg Cys Val Pro His Ile Glu Trp As - #n Pro Asp Leu Asp Cys785 7 - #90 7 - #95 8 -#00- Ser Cys Arg Asp Gly Glu Lys Cys Ala His Hi - #s Ser His His Phe Ser# 815- Leu Asp Ile Asp Val Gly Cys Thr Asp Leu As - #n Glu Asp Leu Gly Val# 830- Trp Val Ile Phe Lys Ile Lys Thr Gln Asp Gl - #y His Ala Arg Leu Gly# 845- Asn Leu Glu Phe Leu Glu Glu Lys Pro Leu Le - #u Gly Glu Ala Leu Ala# 860- Arg Val Lys Arg Ala Glu Lys Lys Trp Arg As - #p Lys Arg Glu Gln Leu865 8 - #70 8 - #75 8 -#80- Gln Phe Glu Thr Asn Ile Val Tyr Lys Glu Al - #a Lys Glu Ser Val Asp# 895- Ala Leu Phe Val Asp Ser His Tyr Asn Arg Le - #u Gln Ala Asp Thr Asn# 910- Ile Thr Met Ile His Ala Ala Asp Lys Arg Va - #l His Arg Ile Arg Glu# 925- Ala Tyr Leu Pro Glu Leu Ser Val Ile Pro Gl - #y Val Asn Ala Asp Ile# 940- Phe Glu Glu Leu Glu Gly Leu Ile Phe Thr Al - #a Phe Ser Leu Tyr Asp945 9 - #50 9 - #55 9 -#60- Ala Arg Asn Ile Ile Lys Asn Gly Asp Phe As - #n Asn Gly Leu Ser Cys# 975- Trp Asn Val Lys Gly His Val Asp Ile Gln Gl - #n Asn Asp His Arg Ser# 990- Val Leu Val Val Pro Glu Trp Glu Ser Glu Va - #l Ser Gln Glu Val Arg# 10050- Val Cys Pro Gly Arg Gly Tyr Ile Leu Arg Va - #l Thr Ala Tyr Lys Glu# 10205- Gly Tyr Gly Glu Gly Cys Val Thr Ile His Gl - #u Ile Glu Asp Asn Thr# 10401030 - # 1035- Asp Glu Leu Lys Phe Ser Asn Cys Ile Glu Gl - #u Glu Val Tyr Pro Thr# 10550- Asp Thr Gly Asn Asp Tyr Thr Ala His Gln Gl - #y Thr Thr Gly Cys Ala# 10705- Asp Ala Cys Asn Ser Arg Asn Val Gly Tyr Gl - #u Asp Gly Tyr Glu Ile# 10850- Asn Thr Thr Ala Ser Val Asn Tyr Lys Pro Th - #r Tyr Glu Glu Glu Met# 11005- Tyr Thr Asp Val Arg Arg Asp Asn His Cys Gl - #u Tyr Asp Arg Gly Tyr# 11201110 - # 1115- Gly Asn His Thr Pro Leu Pro Ala Gly Tyr Va - #l Thr Lys Glu Leu Glu# 11350- Tyr Phe Pro Glu Thr Asp Thr Val Trp Ile Gl - #u Ile Gly Glu Thr Glu# 11505- Gly Thr Phe Ile Val Asp Ser Val Glu Leu Le - #u Leu Met Glu Glu# 11650- (2) INFORMATION FOR SEQ ID NO:3:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 3934 base (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: circular- (ii) MOLECULE TYPE: DNA (genomic)- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 67..3756- (ix) FEATURE: (A) NAME/KEY: misc.sub.-- - #feature (B) LOCATION: 2253..2272- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:- AAACTATTCA ATGGAGAAAA ATTGAATAGT TGTAATGTAA GCACACCGAA AA - #AAGGAGGA 60#GAA ATT ATA AAT GCT 108AA AAT GAG AAT Leu Thr Ser Asn Arg Lys As - #n Glu Asn Glu Ile Ile Asn Ala# 10- TTA TCG ATT CCA ACG GTA TCG AAT CCT TCC AC - #G CAA ATG AAT CTA TCA 156Leu Ser Ile Pro Thr Val Ser Asn Pro Ser Th - #r Gln Met Asn Leu Ser# 30- CCA GAT GCT CGT ATT GAA GAT AGC TTG TGT GT - #A GCC GAG GTG AAC AAT 204Pro Asp Ala Arg Ile Glu Asp Ser Leu Cys Va - #l Ala Glu Val Asn Asn# 45- ATT GAT CCA TTT GTT AGC GCA TCA ACA GTC CA - #A ACG GGT ATA AAC ATA 252Ile Asp Pro Phe Val Ser Ala Ser Thr Val Gl - #n Thr Gly Ile Asn Ile# 60- GCT GGT AGA ATA TTG GGC GTA TTA GGT GTG CC - #G TTT GCT GGA CAA CTA 300Ala Gly Arg Ile Leu Gly Val Leu Gly Val Pr - #o Phe Ala Gly Gln Leu# 75- GCT AGT TTT TAT AGT TTT CTT GTT GGG GAA TT - #A TGG CCT AGT GGC AGA 348Ala Ser Phe Tyr Ser Phe Leu Val Gly Glu Le - #u Trp Pro Ser Gly Arg# 90- GAT CCA TGG GAA ATT TTC CTG GAA CAT GTA GA - #A CAA CTT ATA AGA CAA 396Asp Pro Trp Glu Ile Phe Leu Glu His Val Gl - #u Gln Leu Ile Arg Gln#110- CAA GTA ACA GAA AAT ACT AGG AAT ACG GCT AT - #T GCT CGA TTA GAA GGT 444Gln Val Thr Glu Asn Thr Arg Asn Thr Ala Il - #e Ala Arg Leu Glu Gly# 125- CTA GGA AGA GGC TAT AGA TCT TAC CAG CAG GC - #T CTT GAA ACT TGG TTA 492Leu Gly Arg Gly Tyr Arg Ser Tyr Gln Gln Al - #a Leu Glu Thr Trp Leu# 140- GAT AAC CGA AAT GAT GCA AGA TCA AGA AGC AT - #T ATT CTT GAG CGC TAT 540Asp Asn Arg Asn Asp Ala Arg Ser Arg Ser Il - #e Ile Leu Glu Arg Tyr# 155- GTT GCT TTA GAA CTT GAC ATT ACT ACT GCT AT - #A CCG CTT TTC AGA ATA 588Val Ala Leu Glu Leu Asp Ile Thr Thr Ala Il - #e Pro Leu Phe Arg Ile# 170- CGA AAT GAA GAA GTT CCA TTA TTA ATG GTA TA - #T GCT CAA GCT GCA AAT 636Arg Asn Glu Glu Val Pro Leu Leu Met Val Ty - #r Ala Gln Ala Ala Asn175 1 - #80 1 - #85 1 -#90- TTA CAC CTA TTA TTA TTG AGA GAC GCA TCC CT - #T TTT GGT AGT GAA TGG 684Leu His Leu Leu Leu Leu Arg Asp Ala Ser Le - #u Phe Gly Ser Glu Trp# 205- GGG ATG GCA TCT TCC GAT GTT AAC CAA TAT TA - #C CAA GAA CAA ATC AGA 732Gly Met Ala Ser Ser Asp Val Asn Gln Tyr Ty - #r Gln Glu Gln Ile Arg# 220- TAT ACA GAG GAA TAT TCT AAC CAT TGC GTA CA - #A TGG TAT AAT ACA GGG 780Tyr Thr Glu Glu Tyr Ser Asn His Cys Val Gl - #n Trp Tyr Asn Thr Gly# 235- CTA AAT AAC TTA AGA GGG ACA AAT GCT GAA AG - #T TGG TTG CGG TAT AAT 828Leu Asn Asn Leu Arg Gly Thr Asn Ala Glu Se - #r Trp Leu Arg Tyr Asn# 250- CAA TTC CGT AGA GAC CTA ACG TTA GGG GTA TT - #A GAT TTA GTA GCC CTA 876Gln Phe Arg Arg Asp Leu Thr Leu Gly Val Le - #u Asp Leu Val Ala Leu255 2 - #60 2 - #65 2 -#70- TTC CCA AGC TAT GAT ACT CGC ACT TAT CCA AT - #C AAT ACG AGT GCT CAG 924Phe Pro Ser Tyr Asp Thr Arg Thr Tyr Pro Il - #e Asn Thr Ser Ala Gln# 285- TTA ACA AGA GAA ATT TAT ACA GAT CCA ATT GG - #G AGA ACA AAT GCA CCT 972Leu Thr Arg Glu Ile Tyr Thr Asp Pro Ile Gl - #y Arg Thr Asn Ala Pro# 300- TCA GGA TTT GCA AGT ACG AAT TGG TTT AAT AA - #T AAT GCA CCA TCG TTT1020Ser Gly Phe Ala Ser Thr Asn Trp Phe Asn As - #n Asn Ala Pro Ser Phe# 315- TCT GCC ATA GAG GCT GCC ATT TTC AGG CCT CC - #G CAT CTA CTT GAT TTT1068Ser Ala Ile Glu Ala Ala Ile Phe Arg Pro Pr - #o His Leu Leu Asp Phe# 330- CCA GAA CAA CTT ACA ATT TAC AGT GCA TCA AG - #C CGT TGG AGT AGC ACT1116Pro Glu Gln Leu Thr Ile Tyr Ser Ala Ser Se - #r Arg Trp Ser Ser Thr335 3 - #40 3 - #45 3 -#50- CAA CAT ATG AAT TAT TGG GTG GGA CAT AGG CT - #T AAC TTC CGC CCA ATA1164Gln His Met Asn Tyr Trp Val Gly His Arg Le - #u Asn Phe Arg Pro Ile# 365- GGA GGG ACA TTA AAT ACC TCA ACA CAA GGA CT - #T ACT AAT AAT ACT TCA1212Gly Gly Thr Leu Asn Thr Ser Thr Gln Gly Le - #u Thr Asn Asn Thr Ser# 380- ATT AAT CCT GTA ACA TTA CAG TTT ACG TCT CG - #A GAC GTT TAT AGA ACA1260Ile Asn Pro Val Thr Leu Gln Phe Thr Ser Ar - #g Asp Val Tyr Arg Thr# 395- GAA TCA AAT GCA GGG ACA AAT ATA CTA TTT AC - #T ACT CCT GTG AAT GGA1308Glu Ser Asn Ala Gly Thr Asn Ile Leu Phe Th - #r Thr Pro Val Asn Gly# 410- GTA CCT TGG GCT AGA TTT AAT TTT ATA AAC CC - #T CAG AAT ATT TAT GAA1356Val Pro Trp Ala Arg Phe Asn Phe Ile Asn Pr - #o Gln Asn Ile Tyr Glu415 4 - #20 4 - #25 4 -#30- AGA GGC GCC ACT ACC TAC AGT CAA CCG TAT CA - #G GGA GTT GGG ATT CAA1404Arg Gly Ala Thr Thr Tyr Ser Gln Pro Tyr Gl - #n Gly Val Gly Ile Gln# 445- TTA TTT GAT TCA GAA ACT GAA TTA CCA CCA GA - #A ACA ACA GAA CGA CCA1452Leu Phe Asp Ser Glu Thr Glu Leu Pro Pro Gl - #u Thr Thr Glu Arg Pro# 460- AAT TAT GAA TCA TAT AGT CAT AGA TTA TCT CA - #T ATA GGA CTA ATC ATA1500Asn Tyr Glu Ser Tyr Ser His Arg Leu Ser Hi - #s Ile Gly Leu Ile Ile# 475- GGA AAC ACT TTG AGA GCA CCA GTC TAT TCT TG - #G ACG CAT CGT AGT GCA1548Gly Asn Thr Leu Arg Ala Pro Val Tyr Ser Tr - #p Thr His Arg Ser Ala# 490- GAT CGT ACG AAT ACG ATT GGA CCA AAT AGA AT - #T ACA CAA ATA CCA TTG1596Asp Arg Thr Asn Thr Ile Gly Pro Asn Arg Il - #e Thr Gln Ile Pro Leu495 5 - #00 5 - #05 5 -#10- GTA AAA GCA CTG AAT CTT CAT TCA GGT GTT AC - #T GTT GTT GGA GGG CCA1644Val Lys Ala Leu Asn Leu His Ser Gly Val Th - #r Val Val Gly Gly Pro# 525- GGA TTT ACA GGT GGG GAT ATC CTT CGT AGA AC - #A AAT ACG GGT ACA TTT1692Gly Phe Thr Gly Gly Asp Ile Leu Arg Arg Th - #r Asn Thr Gly Thr Phe# 540- GGA GAT ATA CGA TTA AAT ATT AAT GTG CCA TT - #A TCC CAA AGA TAT CGC1740Gly Asp Ile Arg Leu Asn Ile Asn Val Pro Le - #u Ser Gln Arg Tyr Arg# 555- GTA AGG ATT CGT TAT GCT TCT ACT ACA GAT TT - #A CAA TTT TTC ACG AGA1788Val Arg Ile Arg Tyr Ala Ser Thr Thr Asp Le - #u Gln Phe Phe Thr Arg# 570- ATT AAT GGA ACC ACT GTT AAT ATT GGT AAT TT - #C TCA AGA ACT ATG AAT1836Ile Asn Gly Thr Thr Val Asn Ile Gly Asn Ph - #e Ser Arg Thr Met Asn575 5 - #80 5 - #85 5 -#90- AGG GGG GAT AAT TTA GAA TAT AGA AGT TTT AG - #A ACT GCA GGA TTT AGT1884Arg Gly Asp Asn Leu Glu Tyr Arg Ser Phe Ar - #g Thr Ala Gly Phe Ser# 605- ACT CCT TTT AAT TTT TTA AAT GCC CAA AGC AC - #A TTC ACA TTG GGT GCT1932Thr Pro Phe Asn Phe Leu Asn Ala Gln Ser Th - #r Phe Thr Leu Gly Ala# 620- CAG AGT TTT TCA AAT CAG GAA GTT TAT ATA GA - #T AGA GTC GAA TTT GTT1980Gln Ser Phe Ser Asn Gln Glu Val Tyr Ile As - #p Arg Val Glu Phe Val# 635- CCA GCA GAG GTA ACA TTT GAG GCA GAA TAT GA - #T TTA GAA AGA GCA CAA2028Pro Ala Glu Val Thr Phe Glu Ala Glu Tyr As - #p Leu Glu Arg Ala Gln# 650- AAG GCG GTG AAT GCT CTG TTT ACT TCT ACA AA - #T CCA AGA AGA TTG AAA2076Lys Ala Val Asn Ala Leu Phe Thr Ser Thr As - #n Pro Arg Arg Leu Lys655 6 - #60 6 - #65 6 -#70- ACA GAT GTG ACA GAT TAT CAT ATT GAC CAA GT - #G TCC AAT ATG GTG GCA2124Thr Asp Val Thr Asp Tyr His Ile Asp Gln Va - #l Ser Asn Met Val Ala# 685- TGT TTA TCA GAT GAA TTT TGC TTG GAT GAG AA - #G CGA GAA TTA TTT GAG2172Cys Leu Ser Asp Glu Phe Cys Leu Asp Glu Ly - #s Arg Glu Leu Phe Glu# 700- AAA GTG AAA TAT GCG AAG CGA CTC AGT GAT GA - #A AGA AAC TTA CTC CAA2220Lys Val Lys Tyr Ala Lys Arg Leu Ser Asp Gl - #u Arg Asn Leu Leu Gln# 715- GAT CCA AAC TTC ACA TTC ATC AGT GGG CAA TT - #A AGT TTC GCA TCC ATC2268Asp Pro Asn Phe Thr Phe Ile Ser Gly Gln Le - #u Ser Phe Ala Ser Ile# 730- GAT GGA CAA TCA AAC TTC CCC TCT ATT AAT GA - #G CTA TCT GAA CAT GGA2316Asp Gly Gln Ser Asn Phe Pro Ser Ile Asn Gl - #u Leu Ser Glu His Gly735 7 - #40 7 - #45 7 -#50- TGG TGG GGA AGT GCG AAT GTT ACC ATT CAG GA - #A GGG AAT GAC GTA TTT2364Trp Trp Gly Ser Ala Asn Val Thr Ile Gln Gl - #u Gly Asn Asp Val Phe# 765- AAA GAG AAT TAC GTC ACA CTA CCG GGT ACT TT - #T AAT GAG TGT TAT CCA2412Lys Glu Asn Tyr Val Thr Leu Pro Gly Thr Ph - #e Asn Glu Cys Tyr Pro# 780- AAT TAT TTA TAT CAA AAA ATA GGA GAG TCA GA - #A TTA AAA GCT TAT ACG2460Asn Tyr Leu Tyr Gln Lys Ile Gly Glu Ser Gl - #u Leu Lys Ala Tyr Thr# 795- CGC TAT CAA TTA AGA GGG TAT ATT GAA GAT AG - #T CAA GAT CTA GAG ATT2508Arg Tyr Gln Leu Arg Gly Tyr Ile Glu Asp Se - #r Gln Asp Leu Glu Ile# 810- TAT TTA ATT CGT TAC AAT GCA AAG CAT GAA AC - #A TTG GAT GTT CCA GGT2556Tyr Leu Ile Arg Tyr Asn Ala Lys His Glu Th - #r Leu Asp Val Pro Gly815 8 - #20 8 - #25 8 -#30- ACC GAT TCC CTA TGG CCG CTT TCA GTT GAA AG - #C CCA ATC GGA AGG TGC2604Thr Asp Ser Leu Trp Pro Leu Ser Val Glu Se - #r Pro Ile Gly Arg Cys# 845- GGA GAA CCA AAT CGA TGC GCA CCA CAT TTT GA - #A TGG AAT CCT GAT CTA2652Gly Glu Pro Asn Arg Cys Ala Pro His Phe Gl - #u Trp Asn Pro Asp Leu# 860- GAT TGT TCC TGC AGA GAT GGA GAA AGA TGT GC - #G CAT CAT TCC CAT CAT2700Asp Cys Ser Cys Arg Asp Gly Glu Arg Cys Al - #a His His Ser His His# 875- TTC ACT TTG GAT ATT GAT GTT GGG TGC ACA GA - #C TTG CAT GAG AAC CTA2748Phe Thr Leu Asp Ile Asp Val Gly Cys Thr As - #p Leu His Glu Asn Leu# 890- GGC GTG TGG GTG GTA TTC AAG ATT AAG ACG CA - #G GAA GGT TAT GCA AGA2796Gly Val Trp Val Val Phe Lys Ile Lys Thr Gl - #n Glu Gly Tyr Ala Arg895 9 - #00 9 - #05 9 -#10- TTA GGA AAT CTG GAA TTT ATC GAA GAG AAA CC - #A TTA ATT GGA GAA GCA2844Leu Gly Asn Leu Glu Phe Ile Glu Glu Lys Pr - #o Leu Ile Gly Glu Ala# 925- CTG TCT CGT GTG AAG AGA GCG GAA AAA AAA TG - #G AGA GAC AAA CGG GAA2892Leu Ser Arg Val Lys Arg Ala Glu Lys Lys Tr - #p Arg Asp Lys Arg Glu# 940- AAA CTA CAA TTG GAA ACA AAA CGA GTA TAT AC - #A GAG GCA AAA GAA GCT2940Lys Leu Gln Leu Glu Thr Lys Arg Val Tyr Th - #r Glu Ala Lys Glu Ala# 955- GTG GAT GCT TTA TTC GTA GAT TCT CAA TAT GA - #T CAA TTA CAA GCG GAT2988Val Asp Ala Leu Phe Val Asp Ser Gln Tyr As - #p Gln Leu Gln Ala Asp# 970- ACA AAC ATT GGC ATG ATT CAT GCG GCA GAT AA - #A CTT GTT CAT CGA ATT3036Thr Asn Ile Gly Met Ile His Ala Ala Asp Ly - #s Leu Val His Arg Ile975 9 - #80 9 - #85 9 -#90- CGA GAG GCG TAT CTT TCA GAA TTA CCT GTT AT - #C CCA GGT GTA AAT GCG3084Arg Glu Ala Tyr Leu Ser Glu Leu Pro Val Il - #e Pro Gly Val Asn Ala# 10050- GAA ATT TTT GAA GAA TTA GAA GGT CAC ATT AT - #C ACT GCA ATG TCC TTA3132Glu Ile Phe Glu Glu Leu Glu Gly His Ile Il - #e Thr Ala Met Ser Leu# 10205- TAC GAT GCG AGA AAT GTC GTT AAA AAT GGT GA - #T TTT AAT AAT GGA TTA3180Tyr Asp Ala Arg Asn Val Val Lys Asn Gly As - #p Phe Asn Asn Gly Leu# 10350- ACA TGT TGG AAT GTA AAA GGG CAT GTA GAT GT - #A CAA CAG AGC CAT CAT3228Thr Cys Trp Asn Val Lys Gly His Val Asp Va - #l Gln Gln Ser His His# 10505- CGT TCT GAC CTT GTT ATC CCA GAA TGG GAA GC - #A GAA GTG TCA CAA GCA3276Arg Ser Asp Leu Val Ile Pro Glu Trp Glu Al - #a Glu Val Ser Gln Ala# 10701060 - # 1065- GTT CGC GTC TGT CCG GGG CGT GGC TAT ATC CT - #T CGT GTC ACA GCG TAC3324Val Arg Val Cys Pro Gly Arg Gly Tyr Ile Le - #u Arg Val Thr Ala Tyr# 10850- AAA GAG GGA TAT GGA GAG GGC TGC GTA ACG AT - #C CAT GAA ATC GAG AAC3372Lys Glu Gly Tyr Gly Glu Gly Cys Val Thr Il - #e His Glu Ile Glu Asn# 11005- AAT ACA GAC GAA CTA AAA TTT AAA AAC TGT GA - #A GAA GAG GAA GTG TAT3420Asn Thr Asp Glu Leu Lys Phe Lys Asn Cys Gl - #u Glu Glu Glu Val Tyr# 11150- CCA ACG GAT ACA GGA ACG TGT AAT GAT TAT AC - #T GCA CAC CAA GGT ACA3468Pro Thr Asp Thr Gly Thr Cys Asn Asp Tyr Th - #r Ala His Gln Gly Thr# 11305- GCA GCA TGT AAT TCC CGT AAT GCT GGA TAT GA - #G GAT GCA TAT GAA GTT3516Ala Ala Cys Asn Ser Arg Asn Ala Gly Tyr Gl - #u Asp Ala Tyr Glu Val# 11501140 - # 1145- GAT ACT ACA GCA TCT GTT AAT TAC AAA CCG AC - #T TAT GAA GAA GAA ACG3564Asp Thr Thr Ala Ser Val Asn Tyr Lys Pro Th - #r Tyr Glu Glu Glu Thr# 11650- TAT ACA GAT GTA CGA AGA GAT AAT CAT TGT GA - #A TAT GAC AGA GGG TAT3612Tyr Thr Asp Val Arg Arg Asp Asn His Cys Gl - #u Tyr Asp Arg Gly Tyr# 11805- GTG AAT TAT CCA CCA GTA CCA GCT GGT TAT GT - #G ACA AAA GAA TTA GAA3660Val Asn Tyr Pro Pro Val Pro Ala Gly Tyr Va - #l Thr Lys Glu Leu Glu# 11950- TAC TTC CCA GAA ACA GAT ACA GTA TGG ATT GA - #G ATT GGA GAA ACG GAA3708Tyr Phe Pro Glu Thr Asp Thr Val Trp Ile Gl - #u Ile Gly Glu Thr Glu# 12105- GGA AAG TTT ATT GTA GAT AGC GTG GAA CTA CT - #C CTC ATG GAA GAATAGGATCA3763Gly Lys Phe Ile Val Asp Ser Val Glu Leu Le - #u Leu Met Glu Glu# 123 1220 - # 1225- CAAGTATAGC AGTTTAATAA ATATTAATTA AAATAGTAGT CTAACTTCCG TT - #CCAATTAA3823- ATAAGTAAAT TACAGTTGTA AAAAGAAAAC GGACATCACT CTTCAGAGAG CG - #ATGTCCGT3883# 3934TGTGCTA ATGATAAATG TGCACGAAAT TATATTGTCA A- (2) INFORMATION FOR SEQ ID NO:4:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 1229 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:- Leu Thr Ser Asn Arg Lys Asn Glu Asn Glu Il - #e Ile Asn Ala Leu Ser# 15- Ile Pro Thr Val Ser Asn Pro Ser Thr Gln Me - #t Asn Leu Ser Pro Asp# 30- Ala Arg Ile Glu Asp Ser Leu Cys Val Ala Gl - #u Val Asn Asn Ile Asp# 45- Pro Phe Val Ser Ala Ser Thr Val Gln Thr Gl - #y Ile Asn Ile Ala Gly# 60- Arg Ile Leu Gly Val Leu Gly Val Pro Phe Al - #a Gly Gln Leu Ala Ser# 80- Phe Tyr Ser Phe Leu Val Gly Glu Leu Trp Pr - #o Ser Gly Arg Asp Pro# 95- Trp Glu Ile Phe Leu Glu His Val Glu Gln Le - #u Ile Arg Gln Gln Val# 110- Thr Glu Asn Thr Arg Asn Thr Ala Ile Ala Ar - #g Leu Glu Gly Leu Gly# 125- Arg Gly Tyr Arg Ser Tyr Gln Gln Ala Leu Gl - #u Thr Trp Leu Asp Asn# 140- Arg Asn Asp Ala Arg Ser Arg Ser Ile Ile Le - #u Glu Arg Tyr Val Ala145 1 - #50 1 - #55 1 -#60- Leu Glu Leu Asp Ile Thr Thr Ala Ile Pro Le - #u Phe Arg Ile Arg Asn# 175- Glu Glu Val Pro Leu Leu Met Val Tyr Ala Gl - #n Ala Ala Asn Leu His# 190- Leu Leu Leu Leu Arg Asp Ala Ser Leu Phe Gl - #y Ser Glu Trp Gly Met# 205- Ala Ser Ser Asp Val Asn Gln Tyr Tyr Gln Gl - #u Gln Ile Arg Tyr Thr# 220- Glu Glu Tyr Ser Asn His Cys Val Gln Trp Ty - #r Asn Thr Gly Leu Asn225 2 - #30 2 - #35 2 -#40- Asn Leu Arg Gly Thr Asn Ala Glu Ser Trp Le - #u Arg Tyr Asn Gln Phe# 255- Arg Arg Asp Leu Thr Leu Gly Val Leu Asp Le - #u Val Ala Leu Phe Pro# 270- Ser Tyr Asp Thr Arg Thr Tyr Pro Ile Asn Th - #r Ser Ala Gln Leu Thr# 285- Arg Glu Ile Tyr Thr Asp Pro Ile Gly Arg Th - #r Asn Ala Pro Ser Gly# 300- Phe Ala Ser Thr Asn Trp Phe Asn Asn Asn Al - #a Pro Ser Phe Ser Ala305 3 - #10 3 - #15 3 -#20- Ile Glu Ala Ala Ile Phe Arg Pro Pro His Le - #u Leu Asp Phe Pro Glu# 335- Gln Leu Thr Ile Tyr Ser Ala Ser Ser Arg Tr - #p Ser Ser Thr Gln His# 350- Met Asn Tyr Trp Val Gly His Arg Leu Asn Ph - #e Arg Pro Ile Gly Gly# 365- Thr Leu Asn Thr Ser Thr Gln Gly Leu Thr As - #n Asn Thr Ser Ile Asn# 380- Pro Val Thr Leu Gln Phe Thr Ser Arg Asp Va - #l Tyr Arg Thr Glu Ser385 3 - #90 3 - #95 4 -#00- Asn Ala Gly Thr Asn Ile Leu Phe Thr Thr Pr - #o Val Asn Gly Val Pro# 415- Trp Ala Arg Phe Asn Phe Ile Asn Pro Gln As - #n Ile Tyr Glu Arg Gly# 430- Ala Thr Thr Tyr Ser Gln Pro Tyr Gln Gly Va - #l Gly Ile Gln Leu Phe# 445- Asp Ser Glu Thr Glu Leu Pro Pro Glu Thr Th - #r Glu Arg Pro Asn Tyr# 460- Glu Ser Tyr Ser His Arg Leu Ser His Ile Gl - #y Leu Ile Ile Gly Asn465 4 - #70 4 - #75 4 -#80- Thr Leu Arg Ala Pro Val Tyr Ser Trp Thr Hi - #s Arg Ser Ala Asp Arg# 495- Thr Asn Thr Ile Gly Pro Asn Arg Ile Thr Gl - #n Ile Pro Leu Val Lys# 510- Ala Leu Asn Leu His Ser Gly Val Thr Val Va - #l Gly Gly Pro Gly Phe# 525- Thr Gly Gly Asp Ile Leu Arg Arg Thr Asn Th - #r Gly Thr Phe Gly Asp# 540- Ile Arg Leu Asn Ile Asn Val Pro Leu Ser Gl - #n Arg Tyr Arg Val Arg545 5 - #50 5 - #55 5 -#60- Ile Arg Tyr Ala Ser Thr Thr Asp Leu Gln Ph - #e Phe Thr Arg Ile Asn# 575- Gly Thr Thr Val Asn Ile Gly Asn Phe Ser Ar - #g Thr Met Asn Arg Gly# 590- Asp Asn Leu Glu Tyr Arg Ser Phe Arg Thr Al - #a Gly Phe Ser Thr Pro# 605- Phe Asn Phe Leu Asn Ala Gln Ser Thr Phe Th - #r Leu Gly Ala Gln Ser# 620- Phe Ser Asn Gln Glu Val Tyr Ile Asp Arg Va - #l Glu Phe Val Pro Ala625 6 - #30 6 - #35 6 -#40- Glu Val Thr Phe Glu Ala Glu Tyr Asp Leu Gl - #u Arg Ala Gln Lys Ala# 655- Val Asn Ala Leu Phe Thr Ser Thr Asn Pro Ar - #g Arg Leu Lys Thr Asp# 670- Val Thr Asp Tyr His Ile Asp Gln Val Ser As - #n Met Val Ala Cys Leu# 685- Ser Asp Glu Phe Cys Leu Asp Glu Lys Arg Gl - #u Leu Phe Glu Lys Val# 700- Lys Tyr Ala Lys Arg Leu Ser Asp Glu Arg As - #n Leu Leu Gln Asp Pro705 7 - #10 7 - #15 7 -#20- Asn Phe Thr Phe Ile Ser Gly Gln Leu Ser Ph - #e Ala Ser Ile Asp Gly# 735- Gln Ser Asn Phe Pro Ser Ile Asn Glu Leu Se - #r Glu His Gly Trp Trp# 750- Gly Ser Ala Asn Val Thr Ile Gln Glu Gly As - #n Asp Val Phe Lys Glu# 765- Asn Tyr Val Thr Leu Pro Gly Thr Phe Asn Gl - #u Cys Tyr Pro Asn Tyr# 780- Leu Tyr Gln Lys Ile Gly Glu Ser Glu Leu Ly - #s Ala Tyr Thr Arg Tyr785 7 - #90 7 - #95 8 -#00- Gln Leu Arg Gly Tyr Ile Glu Asp Ser Gln As - #p Leu Glu Ile Tyr Leu# 815- Ile Arg Tyr Asn Ala Lys His Glu Thr Leu As - #p Val Pro Gly Thr Asp# 830- Ser Leu Trp Pro Leu Ser Val Glu Ser Pro Il - #e Gly Arg Cys Gly Glu# 845- Pro Asn Arg Cys Ala Pro His Phe Glu Trp As - #n Pro Asp Leu Asp Cys# 860- Ser Cys Arg Asp Gly Glu Arg Cys Ala His Hi - #s Ser His His Phe Thr865 8 - #70 8 - #75 8 -#80- Leu Asp Ile Asp Val Gly Cys Thr Asp Leu Hi - #s Glu Asn Leu Gly Val# 895- Trp Val Val Phe Lys Ile Lys Thr Gln Glu Gl - #y Tyr Ala Arg Leu Gly# 910- Asn Leu Glu Phe Ile Glu Glu Lys Pro Leu Il - #e Gly Glu Ala Leu Ser# 925- Arg Val Lys Arg Ala Glu Lys Lys Trp Arg As - #p Lys Arg Glu Lys Leu# 940- Gln Leu Glu Thr Lys Arg Val Tyr Thr Glu Al - #a Lys Glu Ala Val Asp945 9 - #50 9 - #55 9 -#60- Ala Leu Phe Val Asp Ser Gln Tyr Asp Gln Le - #u Gln Ala Asp Thr Asn# 975- Ile Gly Met Ile His Ala Ala Asp Lys Leu Va - #l His Arg Ile Arg Glu# 990- Ala Tyr Leu Ser Glu Leu Pro Val Ile Pro Gl - #y Val Asn Ala Glu Ile# 10050- Phe Glu Glu Leu Glu Gly His Ile Ile Thr Al - #a Met Ser Leu Tyr Asp# 10205- Ala Arg Asn Val Val Lys Asn Gly Asp Phe As - #n Asn Gly Leu Thr Cys# 10401030 - # 1035- Trp Asn Val Lys Gly His Val Asp Val Gln Gl - #n Ser His His Arg Ser# 10550- Asp Leu Val Ile Pro Glu Trp Glu Ala Glu Va - #l Ser Gln Ala Val Arg# 10705- Val Cys Pro Gly Arg Gly Tyr Ile Leu Arg Va - #l Thr Ala Tyr Lys Glu# 10850- Gly Tyr Gly Glu Gly Cys Val Thr Ile His Gl - #u Ile Glu Asn Asn Thr# 11005- Asp Glu Leu Lys Phe Lys Asn Cys Glu Glu Gl - #u Glu Val Tyr Pro Thr# 11201110 - # 1115- Asp Thr Gly Thr Cys Asn Asp Tyr Thr Ala Hi - #s Gln Gly Thr Ala Ala# 11350- Cys Asn Ser Arg Asn Ala Gly Tyr Glu Asp Al - #a Tyr Glu Val Asp Thr# 11505- Thr Ala Ser Val Asn Tyr Lys Pro Thr Tyr Gl - #u Glu Glu Thr Tyr Thr# 11650- Asp Val Arg Arg Asp Asn His Cys Glu Tyr As - #p Arg Gly Tyr Val Asn# 11805- Tyr Pro Pro Val Pro Ala Gly Tyr Val Thr Ly - #s Glu Leu Glu Tyr Phe# 12001190 - # 1195- Pro Glu Thr Asp Thr Val Trp Ile Glu Ile Gl - #y Glu Thr Glu Gly Lys# 12150- Phe Ile Val Asp Ser Val Glu Leu Leu Leu Me - #t Glu Glu# 1225- (2) INFORMATION FOR SEQ ID NO:5:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 20 base (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: circular- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:# 20 GATG__________________________________________________________________________

Number	Name	Date	Kind
5080897	Gonzalez, Jr.	Jan 1992
5204237	Gaertner et al.	Apr 1993

Number	Date	Country
289479	Nov 1988	EPX
295156	Dec 1988	EPX
358557	Mar 1990	EPX
367474	May 1990	EPX
401979	Dec 1990	EPX
405810	Jan 1991	EPX
462721	Dec 1991	EPX
9013651	Nov 1990	WOX
9116434	Oct 1991	WOX

	Number	Date
Parent	474038	Jun 1995
Parent	176865	Dec 1993
Parent	100709	Jul 1993

Transformed plant with Bacillus thuringiensis toxin gene

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

CROSS-REFERENCE TO RELATED APPLICATION

US Referenced Citations (2)

Foreign Referenced Citations (9)

Non-Patent Literature Citations (33)

Divisions (3)